https://www.biopharmatrend.com/about/ https://www.biopharmatrend.com/about/team/ https://www.biopharmatrend.com/about/press-citations/ https://www.biopharmatrend.com/advertising-media-kit/ https://www.biopharmatrend.com/artificial-intelligence/ https://www.biopharmatrend.com/tech-giants/ https://www.biopharmatrend.com/next-gen-tools/ https://www.biopharmatrend.com/biotech-ventures/ https://www.biopharmatrend.com/industry-movers/ https://www.biopharmatrend.com/neurotech/ https://www.biopharmatrend.com/news/ https://www.biopharmatrend.com/interviews/ https://www.biopharmatrend.com/business-intelligence/case-studies/ https://www.biopharmatrend.com/events/ https://www.biopharmatrend.com/business-intelligence/the-bigger-point-beyond-insilicos-aging-research-milestone/ 2026-09-09 https://www.biopharmatrend.com/business-intelligence/the-measurement-challenge-in-longevity-can-aging-biomarkers-and-clocks-close-the-gap/ 2026-09-09 https://www.biopharmatrend.com/business-intelligence/what-the-new-ai-model-releases-by-anthropic-and-openai-change-for-life-sciences/ 2026-09-05 https://www.biopharmatrend.com/business-intelligence/into-the-dark-finding-novel-drug-targets-within-the-depths-of-our-proteome/ 2026-08-31 https://www.biopharmatrend.com/next-gen-tools/beyond-the-code-how-dna-nanotechnology-is-moving-from-molecular-origami-to-programmable-biotech-platforms-1557/ 2026-08-21 https://www.biopharmatrend.com/business-intelligence/seven-healthtech-trends-in-europe-to-watch/ 2026-06-26 https://www.biopharmatrend.com/business-intelligence/self-care-is-not-a-product-its-critical-infrastructure/ 2026-06-19 https://www.biopharmatrend.com/news/ginkgo-datapoints-tangible-scientific-and-inductive-bio-launch-adme-one-a-packaged-adme-service-for-hit-identification-1554/ 2026-05-26 https://www.biopharmatrend.com/artificial-intelligence/ai-wont-replace-clinical-programmers-it-will-split-them-into-two-groups-1553/ 2026-05-11 https://www.biopharmatrend.com/news/novo-nordisk-and-openai-team-up-to-integrate-ai-from-discovery-to-supply-chain-1552/ 2026-04-14 https://www.biopharmatrend.com/news/life-biosciences-gets-80m-as-cellular-rejuvenation-enters-the-clinic-1551/ 2026-04-09 https://www.biopharmatrend.com/news/jeito-closes-1b-fund-europes-largest-independent-biopharma-raise-1550/ 2026-04-09 https://www.biopharmatrend.com/news/anthropic-pays-400m-for-an-ai-biotech-with-fewer-than-ten-people-1549/ 2026-04-07 https://www.biopharmatrend.com/news/epia-neuro-wants-to-decode-brains-movement-intentions-after-stroke-1548/ 2026-04-02 https://www.biopharmatrend.com/news/generare-raises-20m-to-explore-uncharacterized-chemical-space-from-microbial-dna-1547/ 2026-04-01 https://www.biopharmatrend.com/news/envedas-ai-discovered-drug-shows-early-atopic-dermatitis-relief-1546/ 2026-03-31 https://www.biopharmatrend.com/news/lilly-signs-275b-ai-drug-discovery-deal-with-insilico-1545/ 2026-03-30 https://www.biopharmatrend.com/news/meta-open-sources-foundation-model-that-predicts-brain-responses-to-speech-video-and-text-1544/ 2026-03-26 https://www.biopharmatrend.com/news/two-ex-gsk-ai-leads-go-stealth-with-a-new-oncology-drug-discovery-startup-1543/ 2026-03-26 https://www.biopharmatrend.com/news/tempus-and-daiichi-sankyo-partner-on-ai-guided-cancer-biomarker-discovery-1542/ 2026-03-25 https://www.biopharmatrend.com/news/bioptimus-launches-multimodal-tissue-atlas-across-three-continents-1541/ 2026-03-25 https://www.biopharmatrend.com/news/merck-signs-20m-deal-with-quotient-to-find-ibd-targets-using-somatic-genomics-1540/ 2026-03-24 https://www.biopharmatrend.com/news/insitro-and-bristol-myers-squibb-add-new-ai-found-targets-in-als-research-1539/ 2026-03-23 https://www.biopharmatrend.com/news/latent-labs-launches-ai-agent-for-antibody-design-from-a-single-text-prompt-1538/ 2026-03-23 https://www.biopharmatrend.com/news/earendil-labs-gets-787m-to-push-ai-designed-antibodies-toward-the-clinic-1537/ 2026-03-23 https://www.biopharmatrend.com/news/ai-guided-brain-implant-for-memory-loss-gets-fda-breakthrough-status-1536/ 2026-03-19 https://www.biopharmatrend.com/news/alphafold-database-now-includesprotein-pair-interactions-1534/ 2026-03-18 https://www.biopharmatrend.com/news/dyno-launches-open-source-agentic-protein-design-suite-at-gtc-2026-1535/ 2026-03-18 https://www.biopharmatrend.com/news/basecamp-launches-trillion-gene-atlas-targeting-over-100-million-species-for-better-ai-training-data-1533/ 2026-03-18 https://www.biopharmatrend.com/news/xaira-therapeutics-launches-x-cell-its-first-virtual-cell-model-1532/ 2026-03-17 https://www.biopharmatrend.com/news/roche-launches-its-own-ai-factory-for-drug-development-1531/ 2026-03-16 https://www.biopharmatrend.com/news/arctoris-opens-biophysics-centre-to-target-data-bottleneck-in-ai-drug-design-1530/ 2026-03-16 https://www.biopharmatrend.com/news/macrocyclic-peptide-startup-unnatural-products-raises-45m-series-b-after-35b-in-pharma-deals-1529/ 2026-03-16 https://www.biopharmatrend.com/news/first-invasive-bci-for-paralysis-cleared-for-everyday-use-in-china-1528/ 2026-03-13 https://www.biopharmatrend.com/business-intelligence/unlocking-the-full-potential-of-precision-medicine-why-companion-diagnostics-must-start-at-discovery/ 2026-03-13 https://www.biopharmatrend.com/artificial-intelligence/from-electronic-noses-to-agentic-drug-design-what-cancer-ai-looks-like-now-1526/ 2026-03-13 https://www.biopharmatrend.com/news/breakout-ventures-raises-114m-for-neuroscience-and-ai-driven-startups-1524/ 2026-03-10 https://www.biopharmatrend.com/news/deepmind-mit-alumni-raise-135m-to-build-generative-knowledge-discovery-ai-1525/ 2026-03-10 https://www.biopharmatrend.com/news/open-radiology-ai-model-released-for-ct-mri-analysis-1523/ 2026-03-06 https://www.biopharmatrend.com/news/ex-neuralink-founder-raises-290m-to-restore-vision-with-a-rice-grain-sized-retinal-implant-1522/ 2026-03-05 https://www.biopharmatrend.com/news/liquid-ai-and-insilico-release-lightweight-on-premise-ai-model-for-drug-discovery-1521/ 2026-03-05 https://www.biopharmatrend.com/news/fda-clears-ai-that-flags-early-stroke-damage-on-routine-brain-ct-scans-1520/ 2026-03-05 https://www.biopharmatrend.com/news/evo-2-open-source-ai-model-for-generative-genomics-validated-and-published-in-nature-1519/ 2026-03-04 https://www.biopharmatrend.com/news/tempus-and-merck-deepen-ai-collaboration-to-study-cancer-biomarkers-1518/ 2026-03-04 https://www.biopharmatrend.com/news/ono-expands-ai-drug-discovery-deal-into-brain-and-immune-diseases-1517/ 2026-03-03 https://www.biopharmatrend.com/news/ginkgo-opens-its-robot-lab-to-researchers-through-a-web-browser-1516/ 2026-03-03 https://www.biopharmatrend.com/news/outpost-bio-raises-35m-to-make-the-human-microbiome-computable-1515/ 2026-03-02 https://www.biopharmatrend.com/news/five-drugmakers-including-recursion-servier-team-up-on-privacy-preserving-admet-ai-1514/ 2026-02-27 https://www.biopharmatrend.com/news/ai-protein-biotech-generate-lands-400-ipo-biggest-in-a-while-1513/ 2026-02-27 https://www.biopharmatrend.com/news/eli-lilly-launches-pharmas-largest-ai-supercomputer-1512/ 2026-02-27 https://www.biopharmatrend.com/news/brain-organoid-gene-therapy-reaches-first-patient-in-pitt-hopkins-syndrome-trial-1511/ 2026-02-26 https://www.biopharmatrend.com/news/new-brain-health-clinic-network-combining-care-research-and-ai-salma-health-launches-with-80m-1510/ 2026-02-26 https://www.biopharmatrend.com/news/breezebio-raises-60m-to-put-its-organ-targeting-gene-delivery-tech-to-the-test-1508/ 2026-02-25 https://www.biopharmatrend.com/news/beacon-launches-to-unite-ai-benchmarking-across-biology-and-drug-discovery-1507/ 2026-02-25 https://www.biopharmatrend.com/news/iqvia-acquires-charles-river-discovery-services-assets-expanding-in-vitro-and-ai-drug-discovery-capabilities-1509/ 2026-02-25 https://www.biopharmatrend.com/news/recursion-logs-fifth-sanofi-milestone-as-joint-immunology-and-oncology-ai-small-molecule-portfolio-builds-toward-up-to-15-programs-1506/ 2026-02-25 https://www.biopharmatrend.com/news/tamarind-bio-raises-136m-to-run-200-ai-and-simulation-models-in-a-no-code-platform-for-bench-scientists-1505/ 2026-02-24 https://www.biopharmatrend.com/news/turbine-raises-25m-to-scale-ai-digital-cell-models-into-immunology-following-astrazeneca-collaboration-1504/ 2026-02-24 https://www.biopharmatrend.com/news/ultima-genomics-launches-faster-dna-sequencers-with-higher-output-1503/ 2026-02-23 https://www.biopharmatrend.com/biotech-ventures/10-notable-ai-powered-biotech-companies-founded-in-2021-500/ 2026-02-20 https://www.biopharmatrend.com/news/y-combinator-backs-yale-spinout-modeling-human-drug-response-with-ai-to-reduce-preclinical-failure-1502/ 2026-02-19 https://www.biopharmatrend.com/news/fda-shifts-drug-approval-policy-what-does-this-mean-for-ai-enabled-therapies-1501/ 2026-02-19 https://www.biopharmatrend.com/news/uks-aria-backs-deep-origin-arctoris-autonomous-scientist-initiative-for-endometriosis-1500/ 2026-02-19 https://www.biopharmatrend.com/news/new-neurodegenerative-disease-biotech-launches-with-175m-to-test-brain-penetrant-antibody-for-alzheimers-1499/ 2026-02-18 https://www.biopharmatrend.com/business-intelligence/companies-applying-ai-to-de-risk-clinical-trials-2026-watchlist/ 2026-02-18 https://www.biopharmatrend.com/news/scribe-and-elli-lilly-reach-second-milestone-in-in-vivo-crispr-collaboration-1498/ 2026-02-17 https://www.biopharmatrend.com/news/terray-updates-its-binding-affinity-predictor-with-diffusion-free-ai-architecture-1497/ 2026-02-16 https://www.biopharmatrend.com/news/in-an-ai-enabled-als-study-digital-twins-support-gene-delivered-antibody-trial-1496/ 2026-02-12 https://www.biopharmatrend.com/artificial-intelligence/international-day-of-women-and-girls-in-science-five-leaders-in-the-ai-life-science-stack-1494/ 2026-02-11 https://www.biopharmatrend.com/news/isomorphic-labs-presents-an-ai-drug-design-engine-that-goes-beyond-alphafold-3-1493/ 2026-02-10 https://www.biopharmatrend.com/news/takeda-signs-17b-ai-enabled-small-molecule-discovery-deal-with-iambic-1492/ 2026-02-09 https://www.biopharmatrend.com/news/flagships-generate-biomedicines-eyes-ipo-amid-reopening-biotech-market-window-1491/ 2026-02-05 https://www.biopharmatrend.com/news/phylo-ai-lab-launches-with-135m-seed-round-introduces-biomni-lab-1489/ 2026-02-04 https://www.biopharmatrend.com/news/inductive-bio-wins-openadmet-blind-challenge-with-machine-learning-models-1488/ 2026-02-03 https://www.biopharmatrend.com/artificial-intelligence/beyond-glp-1-a-new-combination-strategy-shows-up-to-313-in-preclinical-study-1487/ 2026-02-03 https://www.biopharmatrend.com/news/anthropic-hhmi-and-allen-institute-launch-claude-integrated-ai-collaborations-for-life-science-research-1490/ 2026-02-02 https://www.biopharmatrend.com/next-gen-tools/how-digital-health-technologies-are-reshaping-clinical-development-1486/ 2026-01-29 https://www.biopharmatrend.com/news/lilly-lines-up-11b-on-programmable-recombinase-platform-for-hearing-loss-gene-editing-1484/ 2026-01-28 https://www.biopharmatrend.com/news/this-ai-ready-single-molecule-proteomics-16m-grant-targets-parkinsons-alpha-synuclein-1485/ 2026-01-28 https://www.biopharmatrend.com/news/fda-greenlights-first-human-trial-of-epigenetic-rejuvenation-therapy-for-vision-loss-1483/ 2026-01-28 https://www.biopharmatrend.com/artificial-intelligence/this-company-claims-world-first-ai-models-for-programmable-gene-insertion-1482/ 2026-01-28 https://www.biopharmatrend.com/news/antheia-adds-24m-in-series-c-extension-to-expand-us-biosynthetic-drug-manufacturing-1481/ 2026-01-27 https://www.biopharmatrend.com/news/in-another-major-rd-deal-insilico-taps-chinese-pharma-for-ai-designed-cardiometabolic-drugs-1480/ 2026-01-27 https://www.biopharmatrend.com/neurotech/neurotech-trends-in-2025-when-use-cases-started-driving-design-1478/ 2026-01-23 https://www.biopharmatrend.com/news/insilico-medicine-launches-ai-gym-for-llms-and-secures-fda-clearance-for-ai-designed-nlrp3-inhibitor-1479/ 2026-01-23 https://www.biopharmatrend.com/news/tempus-launches-paige-predict-following-81m-paige-ai-acquisition-1476/ 2026-01-21 https://www.biopharmatrend.com/news/chatgpt-for-doctors-raises-250m-series-d-at-12b-valuation-1477/ 2026-01-21 https://www.biopharmatrend.com/news/bioage-to-begin-mid-2026-trial-of-oral-nlrp3-inhibitor-in-diabetic-macular-edema-1474/ 2026-01-20 https://www.biopharmatrend.com/news/in-a-66m-deal-insilico-medicine-and-hygtia-will-develop-an-ai-designed-brain-penetrant-nlrp3-inhibitor-for-cns-diseases-1473/ 2026-01-20 https://www.biopharmatrend.com/news/in-one-day-ai-drug-discovery-touched-big-pharma-the-clinic-regulators-and-public-science-1471/ 2026-01-20 https://www.biopharmatrend.com/news/isomorphic-labs-and-johnson-johnson-partner-on-ai-driven-multi-modality-drug-discovery-1472/ 2026-01-20 https://www.biopharmatrend.com/news/scribe-to-start-first-human-trial-of-one-time-crispr-therapy-for-cardiovascular-disease-1475/ 2026-01-20 https://www.biopharmatrend.com/news/openai-backs-ultrasound-based-brain-computer-interface-startup-with-252m-seed-round-1470/ 2026-01-16 https://www.biopharmatrend.com/news/insilico-deploys-its-chemistry-foundation-model-on-microsoft-discovery-platform-1467/ 2026-01-15 https://www.biopharmatrend.com/news/novo-nordisk-foundation-commits-736m-to-scale-european-life-sciences-1466/ 2026-01-15 https://www.biopharmatrend.com/news/bms-taps-immunais-ai-immune-atlas-to-decode-clinical-trial-responses-1465/ 2026-01-15 https://www.biopharmatrend.com/news/converge-bio-raises-25m-for-generative-ai-systems-in-antibody-and-protein-design-1461/ 2026-01-13 https://www.biopharmatrend.com/news/google-updates-open-medical-ai-suite-with-new-imaging-and-speech-models-launches-100k-developer-hackathon-1464/ 2026-01-13 https://www.biopharmatrend.com/news/tahoe-arc-institute-and-biohub-collaborate-to-release-largest-open-dataset-for-virtual-cell-modeling-1459/ 2026-01-13 https://www.biopharmatrend.com/news/astrazeneca-acquires-modella-ai-to-integrate-foundation-models-into-global-oncology-rd-1463/ 2026-01-13 https://www.biopharmatrend.com/news/illumina-launches-billion-cell-crispr-dataset-for-ai-driven-drug-discovery-built-with-astrazeneca-merck-and-lilly-1469/ 2026-01-13 https://www.biopharmatrend.com/news/vantai-renames-raises-80m-to-scale-ai-platform-for-proximity-based-drug-discovery-1468/ 2026-01-13 https://www.biopharmatrend.com/news/immunai-offers-free-single-cell-multi-omics-to-three-academic-centers-while-growing-its-ai-atlas-1462/ 2026-01-13 https://www.biopharmatrend.com/news/thermo-fisher-teams-with-nvidia-and-tetrascience-to-bring-ai-into-the-lab-1460/ 2026-01-12 https://www.biopharmatrend.com/news/anthropic-launches-claude-for-healthcare-at-jpm26-1458/ 2026-01-12 https://www.biopharmatrend.com/news/nvidia-and-lilly-launch-1b-ai-co-innovation-hub-for-drug-discovery-in-south-san-francisco-1457/ 2026-01-12 https://www.biopharmatrend.com/news/owkin-and-nvidia-partner-to-advance-agentic-ai-models-for-biology-1456/ 2026-01-12 https://www.biopharmatrend.com/news/after-ipo-ai-drug-developer-insilico-medicine-advances-gut-restricted-phd-inhibitor-into-phase-ii-ibd-trial-1454/ 2026-01-12 https://www.biopharmatrend.com/news/manas-ai-and-schrodinger-partner-on-deep-integration-of-physics-based-modeling-into-ai-drug-discovery-platform-1453/ 2026-01-12 https://www.biopharmatrend.com/news/boltz-pbc-launches-with-28m-seed-round-pfizer-collaboration-and-three-guarantees-1455/ 2026-01-12 https://www.biopharmatrend.com/news/crisprs-first-one-patient-success-is-becoming-a-company-aurora-launches-with-16m-to-scale-bespoke-gene-editing-1452/ 2026-01-09 https://www.biopharmatrend.com/news/schrodinger-adds-eli-lillys-ai-drug-discovery-models-to-its-molecular-design-platform-1451/ 2026-01-09 https://www.biopharmatrend.com/news/ai-unicorn-chai-discovery-and-eli-lilly-to-train-custom-ai-models-for-biologics-design-1450/ 2026-01-09 https://www.biopharmatrend.com/news/servier-signs-1b-plus-multi-target-ai-drug-discovery-partnership-with-iktos-1449/ 2026-01-08 https://www.biopharmatrend.com/news/eli-lilly-makes-its-ai-models-available-to-biotech-sector-via-benchling-1448/ 2026-01-08 https://www.biopharmatrend.com/news/medable-releases-new-ai-agent-to-automate-trial-master-file-processing-1447/ 2026-01-08 https://www.biopharmatrend.com/news/gsk-licenses-ai-based-virtual-cell-models-from-noetik-in-five-year-oncology-research-agreement-1446/ 2026-01-08 https://www.biopharmatrend.com/news/eli-lilly-signs-up-to-950m-ai-guided-cancer-therapeutics-deal-with-indupro-1445/ 2026-01-08 https://www.biopharmatrend.com/news/openai-launches-chatgpt-health-trained-with-physician-oversight-and-healthbench-evaluation-1444/ 2026-01-08 https://www.biopharmatrend.com/news/bayer-enters-three-year-ai-antibody-discovery-collaboration-with-cradle-1443/ 2026-01-07 https://www.biopharmatrend.com/business-intelligence/from-animals-to-algorithms-how-ai-brings-drug-testing-closer-to-human-biology/ 2026-01-07 https://www.biopharmatrend.com/news/somite-ai-rebrands-as-cellular-intelligence-as-it-builds-a-universal-virtual-cell-signaling-model-1441/ 2026-01-07 https://www.biopharmatrend.com/news/1910-releases-ai-model-that-designs-cell-permeable-macrocyclic-peptides-1440/ 2026-01-06 https://www.biopharmatrend.com/artificial-intelligence/the-emergence-of-diffusion-generative-models-in-accelerating-ai-drug-discovery-652/ 2026-01-06 https://www.biopharmatrend.com/news/insilico-medicine-and-servier-enter-up-to-888m-oncology-rd-deal-1439/ 2026-01-05 https://www.biopharmatrend.com/news/insilico-medicine-raises-us290-million-in-hong-kongs-largest-biotech-ipo-of-2025-1438/ 2025-12-30 https://www.biopharmatrend.com/news/novo-nordisk-scores-major-win-as-oral-weight-loss-pill-gets-fda-nod-and-the-race-for-obesity-drugs-just-got-hotter-1437/ 2025-12-23 https://www.biopharmatrend.com/news/ai-drug-developer-insilico-medicine-files-for-hong-kong-ipo-aims-to-raise-292m-1436/ 2025-12-18 https://www.biopharmatrend.com/news/bioptimus-releases-multimodal-world-model-for-biology-covering-histology-transcriptomics-and-clinical-data-1435/ 2025-12-17 https://www.biopharmatrend.com/next-gen-tools/beyond-traditional-medicine-exploring-the-revolutionary-therapies-transforming-patient-care-634/ 2025-12-16 https://www.biopharmatrend.com/artificial-intelligence/latent-labs-unveils-ai-model-generating-antibodies-with-low-immunogenicity-and-drug-like-properties-1434/ 2025-12-16 https://www.biopharmatrend.com/news/openai-backed-chai-discovery-raises-130m-at-13b-valuation-to-scale-ai-driven-antibody-design-1432/ 2025-12-15 https://www.biopharmatrend.com/neurotech/top-10-companies-shaping-the-brain-computer-interface-landscape-invasive-vs-non-invasive-bci-technology-650/ 2025-12-14 https://www.biopharmatrend.com/business-intelligence/case-studies/unified-discovery-how-ascends-conversational-ai-bridges-internal-and-public-data-for-accelerated-oncology-insights/ 2025-12-10 https://www.biopharmatrend.com/news/insilico-medicine-reports-ai-designed-protac-that-degrades-and-inhibits-pkmyt1-1430/ 2025-12-09 https://www.biopharmatrend.com/business-intelligence/why-european-life-sciences-momentum-may-finally-become-unstoppable/ 2025-12-08 https://www.biopharmatrend.com/next-gen-tools/ai-and-cryo-em-a-powerful-alliance-for-unraveling-biological-mysteries-635/ 2025-12-04 https://www.biopharmatrend.com/artificial-intelligence/8-notable-companies-making-strides-in-decentralized-clinical-trials-636/ 2025-12-01 https://www.biopharmatrend.com/artificial-intelligence/9-companies-using-artificial-intelligence-to-fight-infectious-diseases-589/ 2025-11-26 https://www.biopharmatrend.com/news/ginkgo-bioworks-launches-open-source-pharmacology-framework-for-ai-drug-discovery-1428/ 2025-11-20 https://www.biopharmatrend.com/news/antheia-and-tapi-announce-strategic-partnership-to-scale-biosynthetic-pharmaceutical-manufacturing-1427/ 2025-11-20 https://www.biopharmatrend.com/post/620-14-publicly-traded-companies-developing-longevity-therapeutics/ 2025-11-20 https://www.biopharmatrend.com/news/terray-launches-experiment-driven-machine-learning-platform-for-small-molecule-discovery-1426/ 2025-11-17 https://www.biopharmatrend.com/artificial-intelligence/recent-ipos-among-ai-driven-platforms-for-drug-discovery-and-biotech-601/ 2025-11-11 https://www.biopharmatrend.com/next-gen-tools/8-online-marketplaces-facilitating-research-in-life-sciences-32/ 2025-11-10 https://www.biopharmatrend.com/news/insilico-and-eli-lilly-launch-100m-collaboration-for-ai-driven-drug-discovery-1425/ 2025-11-10 https://www.biopharmatrend.com/news/insilico-presents-eight-oral-cardiometabolic-drug-candidates-designed-with-ai-1424/ 2025-11-07 https://www.biopharmatrend.com/next-gen-tools/five-companies-leading-the-way-in-3d-bioprinting-699/ 2025-11-04 https://www.biopharmatrend.com/news/roche-and-manifold-bio-will-develop-next-gen-brain-shuttles-for-neurological-diseases-1423/ 2025-11-03 https://www.biopharmatrend.com/next-gen-tools/remote-labs-are-coming-of-age-501/ 2025-11-03 https://www.biopharmatrend.com/biotech-ventures/7-biotechs-fighting-rare-diseases-with-gene-editing-tech-335/ 2025-10-29 https://www.biopharmatrend.com/news/flatiron-health-releases-six-ai-blood-cancer-datasets-covering-505000-patients-1422/ 2025-10-29 https://www.biopharmatrend.com/news/recursion-unveils-whole-genome-microglia-map-with-roche-and-genentech-1421/ 2025-10-29 https://www.biopharmatrend.com/news/genesis-and-nvidia-claim-pearl-surpasses-alphafold-3-in-drug-protein-structure-prediction-1420/ 2025-10-28 https://www.biopharmatrend.com/biotech-ventures/flagship-unveils-ai-covalent-chemistry-startup-50m-commitment-and-pfizer-program-1419/ 2025-10-23 https://www.biopharmatrend.com/business-intelligence/how-ai-powers-synthetic-biology/ 2025-10-23 https://www.biopharmatrend.com/artificial-intelligence/from-gene-editing-to-pathway-design-how-ai-is-transforming-synthetic-biology-642/ 2025-10-22 https://www.biopharmatrend.com/news/iambic-reports-early-clinical-activity-of-ai-designed-her2-inhibitor-1418/ 2025-10-20 https://www.biopharmatrend.com/business-intelligence/key-trends-in-aging-research-where-are-we-now/ 2025-10-19 https://www.biopharmatrend.com/artificial-intelligence/notable-companies-empowering-womens-health-with-ai-701/ 2025-10-17 https://www.biopharmatrend.com/news/astrazeneca-and-ai-powered-immune-mapping-company-immunai-sign-up-to-85m-ibd-target-agreement-1417/ 2025-10-16 https://www.biopharmatrend.com/next-gen-tools/top-rna-biotech-startups-to-watch-in-2021-386/ 2025-10-14 https://www.biopharmatrend.com/news/nabla-bio-and-takeda-expand-ai-driven-antibody-design-partnership-in-billion-dollar-deal-1416/ 2025-10-14 https://www.biopharmatrend.com/business-intelligence/ai-and-crisprconverging-revolutions-in-biomedicine/ 2025-10-13 https://www.biopharmatrend.com/next-gen-tools/7-useful-mobile-apps-for-drug-discovery-professionals-28/ 2025-10-10 https://www.biopharmatrend.com/business-intelligence/inside-big-pharmas-ai-playbook-from-molecule-discovery-to-clinical-trials/ 2025-10-10 https://www.biopharmatrend.com/artificial-intelligence/how-artificial-intelligence-is-reshaping-the-landscape-of-personalized-cancer-treatment-698/ 2025-10-09 https://www.biopharmatrend.com/tech-giants/biopharmas-hunt-for-artificial-intelligence-who-does-what-34/ 2025-10-09 https://www.biopharmatrend.com/artificial-intelligence/unveiling-lantern-pharmas-success-story-in-ai-powered-precision-oncology-690/ 2025-10-09 https://www.biopharmatrend.com/news/sanofi-licenses-benchscis-neurosymbolic-ai-for-global-preclinical-rd-1414/ 2025-10-08 https://www.biopharmatrend.com/neurotech/companies-making-waves-in-neurotech-space-881/ 2025-10-07 https://www.biopharmatrend.com/artificial-intelligence/the-pivotal-role-of-ai-in-clinical-trials-from-digital-twins-to-synthetic-control-arms-176/ 2025-10-07 https://www.biopharmatrend.com/news/ai-model-built-on-transformer-architecture-maps-1300-mouse-brain-regions-in-data-driven-atlas-1413/ 2025-10-07 https://www.biopharmatrend.com/artificial-intelligence/companies-advancing-ai-in-fertility-tech-702/ 2025-10-06 https://www.biopharmatrend.com/industry-movers/astrazeneca-signs-555-million-ai-deal-with-algen-for-crispr-therapies-1412/ 2025-10-06 https://www.biopharmatrend.com/news/singapores-nanyang-biologics-plans-to-go-public-on-nasdaq-in-us15-billion-spac-deal-1410/ 2025-10-02 https://www.biopharmatrend.com/news/bighat-introduces-ai-platform-for-antibody-design-and-optimization-1409/ 2025-10-01 https://www.biopharmatrend.com/news/darpa-funds-polarisqb-to-advance-quantum-aided-drug-design-1408/ 2025-10-01 https://www.biopharmatrend.com/business-intelligence/14-companies-pioneering-ai-foundation-models-in-pharma-and-biotech/ 2025-09-30 https://www.biopharmatrend.com/news/benchsci-and-thermo-fisher-collaborate-to-develop-ai-tools-for-preclinical-rd-1407/ 2025-09-30 https://www.biopharmatrend.com/business-intelligence/why-ai-needs-to-be-at-the-center-of-mrna-design/ 2025-09-30 https://www.biopharmatrend.com/news/arc-institute-reports-megabase-scale-dna-rearrangements-in-human-cells-with-bridge-recombinases-1405/ 2025-09-29 https://www.biopharmatrend.com/news/generative-ai-framework-produces-functional-nanobodies-with-reduced-screening-1404/ 2025-09-29 https://www.biopharmatrend.com/news/aera-reports-preclinical-data-on-lipid-nanoparticle-delivered-in-vivo-car-t-therapy-1403/ 2025-09-29 https://www.biopharmatrend.com/business-intelligence/how-tech-giants-like-nvidia-google-and-microsoft-are-targeting-new-niches-in-biopharma-rd/ 2025-09-26 https://www.biopharmatrend.com/news/proscia-and-pictor-labs-bring-ai-powered-virtual-staining-to-digital-pathology-1402/ 2025-09-26 https://www.biopharmatrend.com/news/healx-expands-rare-oncology-pipeline-through-ai-centered-deal-with-vuja-de-sciences-1401/ 2025-09-25 https://www.biopharmatrend.com/news/pi-health-and-gsk-sign-agreement-for-ai-driven-clinical-trial-collaboration-1400/ 2025-09-25 https://www.biopharmatrend.com/news/uniqure-reports-trial-success-for-experimental-huntingtons-disease-gene-therapy-1399/ 2025-09-25 https://www.biopharmatrend.com/news/daltontx-secures-4-million-seed-funding-to-develop-adaptive-ai-for-drug-discovery-1398/ 2025-09-25 https://www.biopharmatrend.com/news/sanofi-expands-corporate-venture-fund-with-625-million-commitment-1397/ 2025-09-24 https://www.biopharmatrend.com/news/manas-ai-raises-26m-seed-extension-and-appoints-ujjwal-singh-as-cto-and-co-founder-1396/ 2025-09-24 https://www.biopharmatrend.com/news/merck-expands-variational-ai-collaboration-to-up-to-349m-deal-on-two-small-molecule-targets-1395/ 2025-09-23 https://www.biopharmatrend.com/news/mindwalk-advances-ai-designed-glp-1-program-with-dual-pathway-regimen-for-longevity-1394/ 2025-09-23 https://www.biopharmatrend.com/news/netramark-launches-ai-powered-study-of-glioblastoma-clinical-data-1393/ 2025-09-23 https://www.biopharmatrend.com/news/revvity-and-profluent-partner-on-ai-engineered-base-editing-toolkit-1392/ 2025-09-22 https://www.biopharmatrend.com/news/infinitus-partners-with-ibm-consulting-to-automate-patient-access-with-ai-agents-1391/ 2025-09-22 https://www.biopharmatrend.com/news/salt-ai-raises-10m-for-drag-and-drop-platform-to-build-ai-workflows-in-life-sciences-1390/ 2025-09-22 https://www.biopharmatrend.com/news/trially-ai-raises-47m-seed-round-launches-ai-for-clinical-trial-enrollment-1389/ 2025-09-21 https://www.biopharmatrend.com/news/helmholtz-munich-and-parse-biosciences-partner-to-build-largest-human-lung-tissue-perturbation-atlas-1388/ 2025-09-19 https://www.biopharmatrend.com/news/immuto-raises-8m-seed-for-ai-structural-surfaceomics-enters-daiichi-sankyo-oncology-collaboration-1387/ 2025-09-19 https://www.biopharmatrend.com/news/trx-capital-raises-775m-to-back-early-stage-biotech-and-digital-health-1385/ 2025-09-18 https://www.biopharmatrend.com/news/dr-vince-clinical-research-begins-phase-1b-trial-in-atopic-dermatitis-trial-of-envedas-ai-discovered-env-294-1386/ 2025-09-18 https://www.biopharmatrend.com/news/uk-health-ai-push-nvidia-partnerships-back-sovereign-models-from-imaging-to-drug-design-1384/ 2025-09-18 https://www.biopharmatrend.com/news/stanfordarc-team-reports-ai-made-viruses-that-kill-bacteria-1383/ 2025-09-17 https://www.biopharmatrend.com/news/benchsci-reports-new-system-for-extracting-experimental-context-into-a-traceable-evidence-graph-1382/ 2025-09-17 https://www.biopharmatrend.com/news/lantern-pharma-reports-ai-guided-lp-184-meets-phase-1a-endpoints-in-solid-tumors-1381/ 2025-09-17 https://www.biopharmatrend.com/news/biomni-and-sage-partner-on-ai-powered-access-to-biomedical-data-1380/ 2025-09-17 https://www.biopharmatrend.com/news/causaly-introduces-agentic-research-ai-platform-for-life-sciences-rd-1379/ 2025-09-16 https://www.biopharmatrend.com/news/datma-launches-federated-biomarker-explorer-for-health-systems-1378/ 2025-09-16 https://www.biopharmatrend.com/news/medra-launches-ai-driven-platform-for-continuous-scientific-experimentation-1377/ 2025-09-15 https://www.biopharmatrend.com/news/lila-sciences-raises-235m-to-build-autonomous-ai-labs-joins-unicorn-ranks-1376/ 2025-09-15 https://www.biopharmatrend.com/news/google-unveils-ai-for-empirical-software-using-llm-and-tree-search-1375/ 2025-09-15 https://www.biopharmatrend.com/business-intelligence/phesi-reports-glp-1-trials-now-span-100-diseases/ 2025-09-15 https://www.biopharmatrend.com/news/tempus-ai-validates-rna-based-algorithm-for-pancreatic-cancer-therapy-selection-1372/ 2025-09-12 https://www.biopharmatrend.com/news/xtalpi-and-pharmaengine-get-approvals-for-phase-i-trial-of-ai-designed-prmt5-inhibitor-1371/ 2025-09-11 https://www.biopharmatrend.com/news/oracle-amd-and-absci-collaborate-to-scale-ai-driven-drug-discovery-1370/ 2025-09-11 https://www.biopharmatrend.com/business-intelligence/biotech-in-space-microgravity-ventures-and-the-path-to-production/ 2025-09-11 https://www.biopharmatrend.com/news/ge-healthcare-to-acquire-icometrix-for-ai-powered-brain-mri-solutions-1369/ 2025-09-11 https://www.biopharmatrend.com/news/lilly-offers-biotechs-access-to-ai-models-trained-on-1b-in-proprietary-drug-discovery-data-1363/ 2025-09-09 https://www.biopharmatrend.com/news/lilly-partners-with-insitro-on-machine-learning-models-for-small-molecule-discovery-1367/ 2025-09-09 https://www.biopharmatrend.com/news/integra-therapeutics-raises-107-million-to-advance-gene-writing-platform-and-car-t-validation-1366/ 2025-09-08 https://www.biopharmatrend.com/news/proscia-launches-new-ai-pathology-platform-to-link-patients-with-drug-trials-1361/ 2025-09-08 https://www.biopharmatrend.com/business-intelligence/digital-twins-in-rare-diseases-from-virtual-trials-to-personalized-care/ 2025-09-08 https://www.biopharmatrend.com/news/consensus-and-biomni-integrate-agentic-ai-into-biomedical-literature-research-1368/ 2025-09-05 https://www.biopharmatrend.com/news/latchbio-publishes-25-million-cell-open-source-spatial-transcriptomics-atlas-1360/ 2025-09-05 https://www.biopharmatrend.com/news/ketryx-gets-39-million-to-expand-ai-compliance-infrastructure-for-life-sciences-1364/ 2025-09-04 https://www.biopharmatrend.com/news/enveda-secures-150m-series-d-advances-lead-program-adds-ex-pfizer-rd-chief-to-board-1362/ 2025-09-04 https://www.biopharmatrend.com/news/charm-therapeutics-raises-80-million-to-advance-next-generation-menin-inhibitors-for-aml-1365/ 2025-09-02 https://www.biopharmatrend.com/news/potential-breakthrough-in-cell-reprogramming-as-openai-and-retro-biosciences-report-50x-pluripotency-marker-expression-gains-1357/ 2025-08-24 https://www.biopharmatrend.com/news/immunai-opens-free-single-cell-sequencing-program-for-academic-labs-1356/ 2025-08-21 https://www.biopharmatrend.com/news/kyorin-pharmaceutical-adopts-ai-drug-discovery-platform-from-elix-1355/ 2025-08-21 https://www.biopharmatrend.com/news/innovatrix-and-opyl-partner-to-launch-ai-driven-insurance-for-clinical-trial-failure-1354/ 2025-08-21 https://www.biopharmatrend.com/artificial-intelligence/how-ai-is-transforming-medicinal-chemistry-between-discovery-and-manufacture-1353/ 2025-08-21 https://www.biopharmatrend.com/news/ginkgo-inductive-bio-and-tangible-scientific-connect-ai-models-with-automated-labs-for-drug-discovery-1352/ 2025-08-20 https://www.biopharmatrend.com/news/silicon-valleys-molecular-devices-brings-ai-to-brain-organoid-culture-1351/ 2025-08-19 https://www.biopharmatrend.com/news/owkin-to-bring-agentic-ai-into-viennas-oncology-ecosystem-1350/ 2025-08-19 https://www.biopharmatrend.com/news/generative-ai-designs-novel-antibiotics-against-mrsa-and-drug-resistant-gonorrhea-1349/ 2025-08-19 https://www.biopharmatrend.com/news/bioage-labs-begins-phase-1-trial-of-oral-nlrp3-inhibitor-for-obesity-1348/ 2025-08-19 https://www.biopharmatrend.com/news/kriya-raises-313-million-to-advance-gene-therapy-programs-1347/ 2025-08-18 https://www.biopharmatrend.com/news/ai-drug-developer-insilico-medicine-readies-brain-penetrant-inflammasome-therapy-for-parkinsons-trials-1346/ 2025-08-18 https://www.biopharmatrend.com/news/eli-lilly-signs-13-billion-ai-drug-discovery-deal-with-superluminal-1345/ 2025-08-18 https://www.biopharmatrend.com/news/schrodinger-ends-cdc7-inhibitor-program-following-two-patient-deaths-in-aml-trial-1344/ 2025-08-15 https://www.biopharmatrend.com/news/lantern-pharma-reports-on-q2-clinical-trials-new-ai-prediction-tools-1343/ 2025-08-15 https://www.biopharmatrend.com/business-intelligence/digital-pathology-slides-ai-challenges/ 2025-08-15 https://www.biopharmatrend.com/news/fda-authorizes-artera-ai-software-for-prostate-cancer-risk-assessment-1342/ 2025-08-14 https://www.biopharmatrend.com/news/polarisqb-launches-quantum-ai-drug-discovery-platform-for-beta-testing-1341/ 2025-08-13 https://www.biopharmatrend.com/news/gameto-gets-44m-to-complete-us-phase-3-trial-of-stem-cell-derived-ex-vivo-egg-maturation-therapy-1340/ 2025-08-13 https://www.biopharmatrend.com/news/doximity-buys-pathway-medical-for-63m-expands-ai-suite-for-physicians-1339/ 2025-08-13 https://www.biopharmatrend.com/news/asimov-to-apply-ai-driven-cho-expression-platform-in-barda-biomap-filovirus-antibody-manufacturing-1338/ 2025-08-13 https://www.biopharmatrend.com/news/tahoe-therapeutics-raises-30-million-to-expand-single-cell-data-production-for-ai-models-1337/ 2025-08-12 https://www.biopharmatrend.com/news/aging-focused-bioage-posts-q2-2025-results-advances-metabolic-pipeline-and-expands-longevity-data-platform-1336/ 2025-08-11 https://www.biopharmatrend.com/news/strand-therapeutics-secures-153-million-for-programmable-mrna-cancer-therapies-1335/ 2025-08-11 https://www.biopharmatrend.com/business-intelligence/case-studies/from-data-to-discovery-how-benchscis-ascend-builds-a-map-for-biomedical-reasoning/ 2025-08-11 https://www.biopharmatrend.com/news/xtalpi-and-dovetree-finalize-6b-ai-drug-discovery-agreement-1332/ 2025-08-08 https://www.biopharmatrend.com/business-intelligence/building-the-virtual-cell-ai-foundation-models-and-billion-cell-datasets/ 2025-08-08 https://www.biopharmatrend.com/news/chai-discovery-raises-70m-to-expand-zero-shot-biologics-design-ai-platform-1331/ 2025-08-06 https://www.biopharmatrend.com/news/wvu-cancer-institute-adopts-ryght-ai-tools-for-trial-matching-and-enrollment-1330/ 2025-08-06 https://www.biopharmatrend.com/news/nih-foundation-launches-industry-backed-program-to-advance-non-animal-testing-methods-toward-regulatory-use-1328/ 2025-08-05 https://www.biopharmatrend.com/news/recursion-reports-q2-2025-with-7m-sanofi-milestone-announces-clinical-updates-1329/ 2025-08-05 https://www.biopharmatrend.com/news/lantern-pharma-completes-japan-enrollment-in-ai-guided-lung-cancer-study-reports-durable-response-case-1326/ 2025-08-05 https://www.biopharmatrend.com/news/ultromics-gets-55m-to-spot-hidden-heart-failure-with-ai-ultrasound-1327/ 2025-08-04 https://www.biopharmatrend.com/news/synchron-becomes-first-to-achieve-native-thought-control-of-apple-ipad-using-brain-computer-interface-1325/ 2025-08-04 https://www.biopharmatrend.com/business-intelligence/h1-2025-recap-key-signals-from-the-techbio-frontier/ 2025-07-31 https://www.biopharmatrend.com/news/neuralink-begins-uk-clinical-trial-of-brain-implant-for-people-with-paralysis-1323/ 2025-07-31 https://www.biopharmatrend.com/news/ambience-healthcare-raises-243m-in-series-c-reaching-1b-valuation-1321/ 2025-07-30 https://www.biopharmatrend.com/news/profluent-publishes-ai-designed-genome-editor-in-nature-releases-largest-crispr-dataset-1322/ 2025-07-30 https://www.biopharmatrend.com/news/ai-native-formation-bio-licenses-monoclonal-antibody-after-372m-raise-in-2024-1320/ 2025-07-29 https://www.biopharmatrend.com/business-intelligence/ai-scientistsnew-collaborators-for-rare-disease-research/ 2025-07-28 https://www.biopharmatrend.com/news/modi-ventures-closes-88m-second-fund-for-aibiology-convergence-investments-1318/ 2025-07-24 https://www.biopharmatrend.com/news/latent-labs-launches-web-based-ai-tool-for-custom-protein-generation-1317/ 2025-07-22 https://www.biopharmatrend.com/news/uk-rolls-out-national-strategy-to-build-europes-life-sciences-powerhouse-by-2030-1316/ 2025-07-21 https://www.biopharmatrend.com/artificial-intelligence/foundation-models-in-biology-198/ 2025-07-21 https://www.biopharmatrend.com/business-intelligence/how-organoids-and-ai-are-replacing-animal-testing/ 2025-07-18 https://www.biopharmatrend.com/news/japans-elix-launches-ai-drug-discovery-platform-trained-on-confidential-pharma-data-via-federated-learning-1315/ 2025-07-16 https://www.biopharmatrend.com/business-intelligence/can-ai-diagnose-better-than-humans/ 2025-07-11 https://www.biopharmatrend.com/news/google-expands-medgemma-collection-with-multimodal-health-ai-models-for-open-development-1314/ 2025-07-10 https://www.biopharmatrend.com/news/xaira-therapeutics-appoints-biotech-exec-behind-belharra-and-ambys-as-president-and-coo-to-scale-ai-driven-drug-discovery-platform-1312/ 2025-07-09 https://www.biopharmatrend.com/news/nih-ends-funding-for-animal-only-studies-backing-shift-to-new-approach-methodologies-1313/ 2025-07-09 https://www.biopharmatrend.com/news/datma-launches-free-tool-for-pharma-to-assess-biomarker-coverage-in-federated-rwd-1311/ 2025-07-09 https://www.biopharmatrend.com/business-intelligence/emerging-brain-computer-interface-industry-across-chips-ai-and-regulation/ 2025-07-04 https://www.biopharmatrend.com/news/abbvie-acquires-capstan-therapeutics-for-21b-gaining-in-vivo-car-t-platform-targeting-autoimmune-diseases-1310/ 2025-06-30 https://www.biopharmatrend.com/news/chai-discovery-releases-foundation-model-for-zero-shot-antibody-design-with-1620-hit-rates-1309/ 2025-06-30 https://www.biopharmatrend.com/business-intelligence/into-the-unknown-how-artificial-intelligence-can-help-biotech-companies-chart-the-dark-genome/ 2025-06-30 https://www.biopharmatrend.com/news/arc-institute-launches-virtual-cell-challenge-1307/ 2025-06-26 https://www.biopharmatrend.com/news/sandboxaq-releases-public-database-containing-52-million-synthetic-protein-ligand-structures-1306/ 2025-06-26 https://www.biopharmatrend.com/news/deepmind-introduces-new-ai-tool-for-predicting-effects-of-human-dna-variants-1305/ 2025-06-26 https://www.biopharmatrend.com/news/xtalpi-secures-100m-upfront-in-drug-discovery-deal-with-dovetree-eyes-10b-in-milestones-1303/ 2025-06-24 https://www.biopharmatrend.com/news/arc-institute-releases-its-first-virtual-cell-model-trained-on-270-million-cells-1302/ 2025-06-24 https://www.biopharmatrend.com/business-intelligence/12-startups-applying-ai-to-gene-editing-from-custom-crispr-to-zinc-finger-revivals/ 2025-06-20 https://www.biopharmatrend.com/news/nvidia-releases-agentic-ai-blueprint-for-literature-review-and-target-discovery-1301/ 2025-06-19 https://www.biopharmatrend.com/news/nabla-raises-70m-series-c-to-expand-agentic-ai-platform-for-clinical-workflows-1300/ 2025-06-18 https://www.biopharmatrend.com/news/axiom-bio-releases-human-liver-toxicity-dataset-with-130000-compounds-to-advance-ai-based-toxicity-prediction-1299/ 2025-06-18 https://www.biopharmatrend.com/news/xaira-publishes-largest-public-perturb-seq-atlas-to-advance-virtual-cell-modeling-1298/ 2025-06-17 https://www.biopharmatrend.com/news/agenus-and-noetik-partner-to-develop-ai-based-biomarkers-using-virtual-cell-models-1297/ 2025-06-17 https://www.biopharmatrend.com/news/isomorphic-labs-appoints-ben-wolf-as-chief-medical-officer-expands-to-us-hub-in-cambridge-1296/ 2025-06-17 https://www.biopharmatrend.com/news/ryght-ai-raises-3m-to-automate-clinical-trial-site-activation-with-agentic-ai-1295/ 2025-06-17 https://www.biopharmatrend.com/news/astrazeneca-signs-53b-ai-drug-discovery-deal-with-cspc-for-chronic-disease-programs-1294/ 2025-06-16 https://www.biopharmatrend.com/news/insilico-medicine-completes-oversubscribed-series-e-bringing-total-funding-to-123-million-1293/ 2025-06-16 https://www.biopharmatrend.com/news/sofinnova-partners-and-nvidia-collaborate-to-provide-gpu-access-to-ai-driven-life-sciences-startups-1292/ 2025-06-11 https://www.biopharmatrend.com/news/insilico-medicine-launches-its-multimodal-generative-chemistry-model-on-aws-marketplace-1291/ 2025-06-11 https://www.biopharmatrend.com/news/mit-and-recursion-launch-boltz-2-open-source-ai-foundation-model-for-structure-and-binding-affinity-prediction-1289/ 2025-06-07 https://www.biopharmatrend.com/business-intelligence/17-more-biomedical-foundation-models/ 2025-06-07 https://www.biopharmatrend.com/news/futurehouse-debuts-scientific-reasoning-model-trained-for-chemistry-1290/ 2025-06-07 https://www.biopharmatrend.com/news/the-stage-is-set-london-biotechnology-show-2025-1288/ 2025-06-07 https://www.biopharmatrend.com/news/kiin-bio-raises-22m-pre-seed-to-build-ai-platform-of-virtual-scientists-for-drug-discovery-1285/ 2025-06-06 https://www.biopharmatrend.com/business-intelligence/what-is-ai-drug-discovery/ 2025-06-06 https://www.biopharmatrend.com/news/fda-launches-internal-ai-tool-elsa-to-streamline-regulatory-and-scientific-workflows-1287/ 2025-06-06 https://www.biopharmatrend.com/news/sarepta-secures-first-fda-platform-designation-for-gene-therapy-delivery-technology-1286/ 2025-06-06 https://www.biopharmatrend.com/news/using-ai-immunoprecise-discovers-possible-universal-dengue-vaccine-target-1284/ 2025-06-06 https://www.biopharmatrend.com/news/antheia-raises-56m-series-c-to-scale-biosynthetic-drug-ingredient-production-expands-to-asia-1283/ 2025-06-04 https://www.biopharmatrend.com/news/ai-designed-tnik-inhibitor-shows-lung-function-gains-in-ipf-1282/ 2025-06-03 https://www.biopharmatrend.com/news/french-startup-using-ai-and-click-chemistry-to-speed-up-microbial-detection-raises-5m-1280/ 2025-06-02 https://www.biopharmatrend.com/business-intelligence/ai-based-next-generation-phenotyping-for-rare-disease-diagnosis/ 2025-05-30 https://www.biopharmatrend.com/business-intelligence/14-startups-in-ai-protein-design-platforms-specialists-modular-tools/ 2025-05-30 https://www.biopharmatrend.com/news/bioage-preps-brain-penetrant-nlrp3-inhibitor-for-obesity-ind-1279/ 2025-05-29 https://www.biopharmatrend.com/news/nature-study-ai-designs-enpp1-inhibitor-for-immune-modulation-in-cancer-1278/ 2025-05-29 https://www.biopharmatrend.com/news/medable-launches-digital-long-term-follow-up-model-for-cell-and-gene-therapy-trials-1277/ 2025-05-28 https://www.biopharmatrend.com/news/finnish-healthtech-curifylabs-raises-67m-to-automate-compounded-drug-manufacturing-1276/ 2025-05-27 https://www.biopharmatrend.com/news/biostate-ai-raises-12m-to-build-rna-based-foundation-model-for-molecular-diagnostics-1274/ 2025-05-26 https://www.biopharmatrend.com/news/harvard-and-roche-develop-foundation-ai-model-to-predict-and-explain-immunotherapy-response-across-33-cancer-types-1273/ 2025-05-26 https://www.biopharmatrend.com/news/haya-therapeutics-raises-65m-to-develop-rna-drugs-targeting-the-dark-genome-1272/ 2025-05-26 https://www.biopharmatrend.com/news/persist-ai-launches-robotic-cloud-lab-for-formulation-development-raises-12m-series-a-1271/ 2025-05-26 https://www.biopharmatrend.com/news/pusan-national-university-researchers-develop-ai-model-to-identify-therapeutic-gene-targets-using-hypergraphs-1267/ 2025-05-26 https://www.biopharmatrend.com/news/lokavant-releases-ai-based-forecasting-tool-for-clinical-trial-enrollment-1266/ 2025-05-26 https://www.biopharmatrend.com/news/blackfinbio-receives-fda-clearance-to-begin-clinical-trial-for-gene-therapy-in-rare-childhood-motor-disorder-1265/ 2025-05-26 https://www.biopharmatrend.com/news/real-world-study-reports-91-of-tinnitus-patients-improved-with-neuromods-fda-approved-device-1264/ 2025-05-26 https://www.biopharmatrend.com/news/neogenomics-adopts-ultima-genomics-platform-to-expand-sequencing-based-oncology-diagnostics-1263/ 2025-05-26 https://www.biopharmatrend.com/news/molecular-devices-launches-automated-system-for-microbial-colony-picking-1262/ 2025-05-26 https://www.biopharmatrend.com/news/atropos-health-adds-ontada-oncology-data-to-expand-community-cancer-coverage-in-real-world-evidence-network-1261/ 2025-05-26 https://www.biopharmatrend.com/news/deep-genomics-releases-ai-foundation-model-for-microrna-binding-and-mrna-degradation-prediction-1260/ 2025-05-26 https://www.biopharmatrend.com/news/datavant-to-acquire-aetion-expanding-into-end-to-end-real-world-evidence-analytics-for-life-sciences-1259/ 2025-05-26 https://www.biopharmatrend.com/news/dementia-discovery-fund-closes-second-fund-at-269m-bringing-total-raised-to-over-550m-1258/ 2025-05-26 https://www.biopharmatrend.com/news/nih-brain-initiative-backs-toolkit-of-1000-enhancer-aavs-for-cell-type-targeting-in-brain-disorders-1257/ 2025-05-26 https://www.biopharmatrend.com/news/phesi-analyzes-167m-patient-records-finds-colorectal-cancer-has-largest-oncology-rwd-volume-1256/ 2025-05-26 https://www.biopharmatrend.com/news/hp-and-tecan-launch-combined-single-cell-and-reagent-dispenser-report-40x-faster-dosing-for-drug-discovery-1255/ 2025-05-26 https://www.biopharmatrend.com/news/experity-rolls-out-ai-integrated-partner-ecosystem-to-streamline-urgent-care-operations-1254/ 2025-05-26 https://www.biopharmatrend.com/news/ai-model-reconstructs-3d-human-faces-from-dna-with-high-accuracy-raising-privacy-and-forensic-questions-1275/ 2025-05-25 https://www.biopharmatrend.com/news/boehringer-ingelheim-taps-tempus-ai-and-patient-data-to-deepen-cancer-research-pipeline-1253/ 2025-05-23 https://www.biopharmatrend.com/business-intelligence/ai-meets-clinical-trials-recent-policy-shifts-companies-to-watch/ 2025-05-20 https://www.biopharmatrend.com/news/regeneron-acquires-23andme-assets-for-256m-aiming-to-expand-consumer-genomics-and-data-driven-drug-discovery-1252/ 2025-05-19 https://www.biopharmatrend.com/news/oracle-rebuilds-its-ehr-infrastructure-to-support-ai-native-workflows-1251/ 2025-05-16 https://www.biopharmatrend.com/news/first-of-its-kind-crispr-therapy-saves-infant-with-rare-genetic-disorder-1250/ 2025-05-16 https://www.biopharmatrend.com/news/researchers-use-terahertz-imaging-for-first-ever-3d-view-of-cochlea-without-surgery-1249/ 2025-05-14 https://www.biopharmatrend.com/news/medable-launches-ai-enabled-digital-platform-to-streamline-oncology-trials-ahead-of-asco-2025-1248/ 2025-05-14 https://www.biopharmatrend.com/news/absci-doses-first-participants-in-phase-1-trial-of-ai-designed-antibody-for-ibd-1247/ 2025-05-14 https://www.biopharmatrend.com/news/eligo-bioscience-gets-5m-grant-to-advance-gene-editing-skin-therapy-using-bacteria-1246/ 2025-05-14 https://www.biopharmatrend.com/news/kvantify-taps-gefion-ai-supercomputer-to-scale-quantum-chemistry-simulations-for-drug-discovery-1245/ 2025-05-14 https://www.biopharmatrend.com/news/dutch-startup-cryocloud-lands-2m-to-automate-cryo-em-for-drug-discovery-1244/ 2025-05-14 https://www.biopharmatrend.com/news/lantern-pharma-gets-fda-green-light-for-ai-guided-trial-targeting-hard-to-treat-lung-cancer-1242/ 2025-05-13 https://www.biopharmatrend.com/news/openai-introduces-open-benchmark-to-assess-ai-performance-in-realistic-healthcare-scenarios-1241/ 2025-05-13 https://www.biopharmatrend.com/news/insilico-medicine-makes-third-bid-for-hong-kong-ipo-1240/ 2025-05-12 https://www.biopharmatrend.com/news/torontos-intrepid-labs-emerges-with-11m-and-ai-driven-platform-to-rebuild-drug-formulation-rd-1239/ 2025-05-12 https://www.biopharmatrend.com/news/scientists-engineer-precision-tool-for-mitochondrial-dna-manipulation-1238/ 2025-05-10 https://www.biopharmatrend.com/news/khondrion-secures-5m-to-advance-small-molecule-therapy-toward-phase-3-trial-1237/ 2025-05-10 https://www.biopharmatrend.com/news/iktos-brings-its-generative-ai-drug-design-platform-to-aws-marketplace-1236/ 2025-05-09 https://www.biopharmatrend.com/news/crown-bioscience-shows-3d-bone-marrow-model-to-improve-blood-cancer-drug-testing-and-reduce-animal-use-1235/ 2025-05-09 https://www.biopharmatrend.com/news/moderna-to-onboard-rd-teams-to-benchling-platform-for-ai-driven-research-integration-1234/ 2025-05-08 https://www.biopharmatrend.com/news/startup-working-with-italian-hospitals-raises-22m-to-structure-medical-reports-into-care-plans-1233/ 2025-05-07 https://www.biopharmatrend.com/news/north-bristol-nhs-trust-becomes-reference-site-for-fujifilms-digital-pathology-platform-1232/ 2025-05-07 https://www.biopharmatrend.com/news/inductive-bio-raises-25m-to-scale-ai-platform-for-predicting-drug-behavior-before-synthesis-1231/ 2025-05-07 https://www.biopharmatrend.com/news/aunches-etiome-with-50m-to-use-ai-for-stage-specific-drug-target-discovery-1230/ 2025-05-05 https://www.biopharmatrend.com/news/twist-bioscience-spins-out-atlas-data-storage-with-155m-to-commercialize-dna-based-data-storage-1229/ 2025-05-05 https://www.biopharmatrend.com/news/lantern-pharma-advances-ai-guided-drug-into-phase-1b2-trial-for-triple-negative-breast-cancer-1228/ 2025-05-05 https://www.biopharmatrend.com/news/recursion-reports-positive-early-trial-results-for-familial-adenomatous-polyposis-1227/ 2025-05-05 https://www.biopharmatrend.com/artificial-intelligence/how-ai-graphs-and-graphrag-are-set-to-revolutionize-alzheimers-gene-research-and-treatment-1226/ 2025-05-03 https://www.biopharmatrend.com/business-intelligence/the-infrastructure-layer-30-platforms-powering-human-relevant-drug-development/ 2025-05-02 https://www.biopharmatrend.com/news/no-clear-winner-landmark-brain-study-tests-rival-theories-of-consciousness-1225/ 2025-04-30 https://www.biopharmatrend.com/news/nurix-debuts-foundation-model-to-accelerate-small-molecule-drug-discovery-1224/ 2025-04-30 https://www.biopharmatrend.com/news/eli-lilly-partners-with-creyon-bio-in-1b-ai-oligonucleotide-deal-1223/ 2025-04-30 https://www.biopharmatrend.com/news/nih-launches-initiative-to-prioritize-human-based-research-technologies-1222/ 2025-04-30 https://www.biopharmatrend.com/news/axiom-bio-seed-funding-ai-drug-toxicity-1219/ 2025-04-29 https://www.biopharmatrend.com/news/raidium-publishes-promptable-ct-foundation-model-for-tumor-segmentation-1221/ 2025-04-29 https://www.biopharmatrend.com/news/tempus-introduces-loop-an-ai-driven-platform-for-target-discovery-and-validation-1220/ 2025-04-28 https://www.biopharmatrend.com/news/nhs-wales-pilots-paige-ai-tool-to-triage-cancer-cases-1216/ 2025-04-24 https://www.biopharmatrend.com/business-intelligence/novotech-report-over-800-global-ipf-trials-since-2020-led-by-asia-pacific/ 2025-04-24 https://www.biopharmatrend.com/news/immunai-and-parker-institute-to-build-largest-single-cell-dataset-for-real-world-immunotherapy-research-1214/ 2025-04-24 https://www.biopharmatrend.com/news/potato-grows-45m-to-automate-lab-work-with-ai-and-robots-1213/ 2025-04-23 https://www.biopharmatrend.com/news/tempus-astrazeneca-and-pathos-partner-to-build-oncology-foundation-model-using-multimodal-data-1212/ 2025-04-23 https://www.biopharmatrend.com/business-intelligence/the-rise-of-ai-agents-in-biotech-where-are-we-now/ 2025-04-19 https://www.biopharmatrend.com/business-intelligence/23-new-startups-in-ai-drug-development-space-launched-20232025/ 2025-04-18 https://www.biopharmatrend.com/news/genedx-to-acquire-fabric-genomics-to-enable-ai-powered-decentralized-genome-interpretation-1210/ 2025-04-16 https://www.biopharmatrend.com/news/elix-and-prism-biolab-partner-to-tackle-hard-to-drug-protein-targets-with-ai-1209/ 2025-04-16 https://www.biopharmatrend.com/news/netherlands-outlines-2040-biotech-vision-emphasizing-tools-commercialization-and-regulatory-reform-1208/ 2025-04-16 https://www.biopharmatrend.com/news/sanger-institute-and-pacbio-launch-large-scale-long-read-sequencing-effort-to-map-immune-gene-activity-1207/ 2025-04-15 https://www.biopharmatrend.com/news/finalists-announced-for-10m-coller-dolittle-challenge-on-ai-powered-interspecies-communication-1206/ 2025-04-15 https://www.biopharmatrend.com/news/baypine-acquires-clinical-trial-network-cenexel-plans-digital-infrastructure-and-ai-expansion-1205/ 2025-04-15 https://www.biopharmatrend.com/news/biostate-ai-partners-with-accelerated-cure-project-to-develop-ai-models-for-multiple-sclerosis-1204/ 2025-04-15 https://www.biopharmatrend.com/news/scotland-launches-ai-discovery-to-foster-deeptech-ai-startups-for-nhs-healthcare-innovation-1203/ 2025-04-15 https://www.biopharmatrend.com/news/chiba-university-researchers-develop-low-cost-cell-based-assay-to-detect-chemical-induced-epigenetic-changes-1269/ 2025-04-11 https://www.biopharmatrend.com/news/fda-plan-to-replace-animal-testing-with-ai-models-and-human-based-methods-in-drug-evaluation-shift-1202/ 2025-04-11 https://www.biopharmatrend.com/news/ingenixai-secures-9m-to-advance-multimodal-ai-foundation-model-for-simulating-clinical-trials-1201/ 2025-04-10 https://www.biopharmatrend.com/news/recursion-and-enamine-release-ai-curated-screening-libraries-targeting-100-challenging-drug-targets-1199/ 2025-04-09 https://www.biopharmatrend.com/news/first-genetically-engineered-dire-wolf-like-animals-born-1198/ 2025-04-08 https://www.biopharmatrend.com/news/recursion-doses-first-patient-in-phase-1-trial-of-ai-designed-malt1-inhibitor-1197/ 2025-04-08 https://www.biopharmatrend.com/news/iqvia-introduces-a-compact-medical-reasoning-llm-outscoring-larger-models-1196/ 2025-04-07 https://www.biopharmatrend.com/news/verge-genomics-reports-digital-biomarkers-may-track-early-als-progression-in-pre-treatment-trial-phase-1195/ 2025-04-07 https://www.biopharmatrend.com/news/aelius-biotech-raises-750k-to-expand-in-vitro-gut-model-platform-for-drug-and-food-rd-1194/ 2025-04-07 https://www.biopharmatrend.com/news/pharma-supply-chain-tech-firm-skycell-partners-with-microsoft-to-launch-ai-co-pilot-for-shipment-monitoring-1193/ 2025-04-07 https://www.biopharmatrend.com/news/1b-ai-drug-discovery-startup-xaira-therapeutics-appoints-foundation-model-expert-bo-wang-as-head-of-biomedical-ai-1192/ 2025-04-04 https://www.biopharmatrend.com/news/paiges-ai-tool-for-multi-tissue-cancer-detection-gets-fdas-breakthrough-device-designation-1191/ 2025-04-03 https://www.biopharmatrend.com/news/differential-bio-emerges-from-stealth-with-2m-to-scale-ai-driven-biomanufacturing-1190/ 2025-04-03 https://www.biopharmatrend.com/news/medtronic-partners-with-methinks-ai-to-expand-ai-driven-stroke-assessment-in-emea-1188/ 2025-04-02 https://www.biopharmatrend.com/news/siemens-to-acquire-scientific-informatics-firm-dotmatics-for-51b-1187/ 2025-04-02 https://www.biopharmatrend.com/news/aqemia-secures-74m-to-expand-rna-targeting-programs-with-physics-based-generative-ai-1186/ 2025-04-01 https://www.biopharmatrend.com/news/company-behind-alphafold-raises-600m-to-advance-ai-drug-design-and-internal-pipeline-1184/ 2025-03-31 https://www.biopharmatrend.com/business-intelligence/13-foundation-models-startups-industry-updates-and-the-nobel-prize/ 2025-03-28 https://www.biopharmatrend.com/news/turn-bio-acquires-vesicular-delivery-tech-for-epigenetic-therapy-1183/ 2025-03-27 https://www.biopharmatrend.com/news/seca-launches-real-time-body-composition-tracking-platform-for-personalized-patient-care-1182/ 2025-03-27 https://www.biopharmatrend.com/news/oxford-nanoimaging-presents-ml-driven-imaging-solution-for-lipid-nanoparticles-1181/ 2025-03-27 https://www.biopharmatrend.com/news/rsm-uk-calls-on-uk-government-to-boost-life-sciences-sector-ahead-of-new-industrial-strategy-1180/ 2025-03-26 https://www.biopharmatrend.com/news/ai-enabled-3d-imaging-company-presents-new-imaging-interface-for-light-sheet-microscopy-1179/ 2025-03-25 https://www.biopharmatrend.com/business-intelligence/report-nearly-80-of-life-sciences-leaders-considering-virtual-models-for-observational-research/ 2025-03-24 https://www.biopharmatrend.com/news/yc-startup-reactwise-raises-34m-in-pre-seed-to-develop-ai-driven-robotic-labs-for-drug-manufacturing-1177/ 2025-03-24 https://www.biopharmatrend.com/news/roivant-spinout-startup-debuts-ai-model-to-combine-biomolecule-structure-prediction-and-generation-1176/ 2025-03-24 https://www.biopharmatrend.com/news/23andme-files-for-bankruptcy-1175/ 2025-03-24 https://www.biopharmatrend.com/news/lilly-backed-ampersand-raises-65m-for-preclinical-immunology-and-computational-drug-discovery-1171/ 2025-03-21 https://www.biopharmatrend.com/news/microsoft-and-inait-partner-to-develop-brain-inspired-ai-for-finance-and-robotics-1170/ 2025-03-21 https://www.biopharmatrend.com/business-intelligence/12-startups-in-the-digital-twin-healthcare-ecosystem-from-virtual-organs-to-optimized-trials/ 2025-03-20 https://www.biopharmatrend.com/news/proscia-raises-50m-to-expand-ai-pathology-platform-and-precision-medicine-tools-1169/ 2025-03-19 https://www.biopharmatrend.com/news/synchron-and-nvidia-collaborate-on-real-time-neural-processing-for-bcis-1168/ 2025-03-19 https://www.biopharmatrend.com/news/sofinnova-raises-165m-to-back-european-biotech-startups-1167/ 2025-03-19 https://www.biopharmatrend.com/news/ai-tool-maps-cellular-social-networks-to-guide-cancer-treatment-1166/ 2025-03-18 https://www.biopharmatrend.com/news/uk-company-secures-600000-for-3d-lung-model-to-replace-animal-testing-1165/ 2025-03-13 https://www.biopharmatrend.com/business-intelligence/next-generation-sequencing-new-tech-and-companies-to-watch/ 2025-03-13 https://www.biopharmatrend.com/news/elsevier-launches-ai-to-provide-summarized-research-insights-1164/ 2025-03-13 https://www.biopharmatrend.com/news/tempus-acquires-ai-powered-clinical-trial-matching-platform-1163/ 2025-03-13 https://www.biopharmatrend.com/news/insilico-medicine-raises-110m-to-advance-ai-drug-design-unveils-its-humanoid-lab-robot-1162/ 2025-03-12 https://www.biopharmatrend.com/news/lila-sciences-raises-200m-to-automate-scientific-discovery-with-ai-and-robotics-1160/ 2025-03-11 https://www.biopharmatrend.com/news/creation-healthcare-launches-hcp-voice-platform-to-analyze-global-social-media-discourse-among-healthcare-professionals-1268/ 2025-03-10 https://www.biopharmatrend.com/news/immunai-appoints-former-pfizer-rd-chief-to-board-of-directors-1158/ 2025-03-06 https://www.biopharmatrend.com/news/cortical-labs-introduces-biological-computer-built-on-human-brain-cells-1156/ 2025-03-04 https://www.biopharmatrend.com/news/novo-nordisk-and-gensaic-collaborate-on-tissue-targeted-therapies-for-cardiometabolic-diseases-1155/ 2025-03-04 https://www.biopharmatrend.com/news/google-cloud-introduces-multimodal-ai-for-healthcare-at-himss-2025-1154/ 2025-03-03 https://www.biopharmatrend.com/news/vevo-therapeutics-open-sources-largest-single-cell-dataset-with-arc-institute-1152/ 2025-02-25 https://www.biopharmatrend.com/business-intelligence/ai-in-drug-safety-from-concept-to-reality-the-industrys-path-forward/ 2025-02-25 https://www.biopharmatrend.com/news/fuse-vectors-secures-52m-to-develop-cell-free-gene-therapy-technology-1150/ 2025-02-25 https://www.biopharmatrend.com/news/100-billion-reads-per-day-ultima-genomics-expands-sequencing-capacity-and-cuts-costs-by-20-1149/ 2025-02-24 https://www.biopharmatrend.com/news/roche-introduces-new-dna-sequencing-technology-1147/ 2025-02-21 https://www.biopharmatrend.com/news/ai-driven-robotics-lab-identifies-tnik-inhibition-as-a-potential-senomorphic-approach-1146/ 2025-02-21 https://www.biopharmatrend.com/news/illumina-and-broad-institute-launch-spatial-transcriptomics-project-ahead-of-agbt-meeting-1145/ 2025-02-21 https://www.biopharmatrend.com/news/first-in-utero-treatment-for-spinal-muscular-atrophy-shows-promising-results-1144/ 2025-02-21 https://www.biopharmatrend.com/news/this-company-secures-55-million-to-expand-foundation-model-for-small-molecule-drug-discovery-1142/ 2025-02-21 https://www.biopharmatrend.com/news/evo-2-largest-foundation-model-for-genomic-research-across-all-domains-of-life-1143/ 2025-02-20 https://www.biopharmatrend.com/news/sporebio-secures-23m-for-its-ai-driven-handheld-photonic-pathogen-scanner-1141/ 2025-02-20 https://www.biopharmatrend.com/news/amid-federal-cuts-recursions-altitude-lab-launches-pre-seed-fund-1140/ 2025-02-19 https://www.biopharmatrend.com/news/insilico-medicine-reports-preclinical-benchmarks-for-ai-designed-therapeutics-1137/ 2025-02-14 https://www.biopharmatrend.com/news/ai-for-protein-design-deepmind-alums-startup-comes-out-of-stealth-with-50m-1136/ 2025-02-13 https://www.biopharmatrend.com/news/receptorai-and-moexa-pharmaceuticals-partner-to-advance-ai-powered-smad3-inhibitors-1135/ 2025-02-10 https://www.biopharmatrend.com/business-intelligence/combination-therapies-may-be-the-future-of-oncology-how-can-we-navigate-development-challenges-today/ 2025-02-09 https://www.biopharmatrend.com/news/basetwo-raises-115m-for-ai-driven-first-principles-pharmaceutical-manufacturing-optimization-1132/ 2025-01-23 https://www.biopharmatrend.com/news/insilico-medicine-doses-first-patient-in-phase-i-trial-of-ai-designed-pan-tead-inhibitor-1131/ 2025-01-23 https://www.biopharmatrend.com/news/advarra-launches-study-collaboration-solution-to-accelerate-clinical-trial-startup-1130/ 2025-01-22 https://www.biopharmatrend.com/news/rybodyn-uncovers-dark-proteome-secures-4m-pre-seed-for-cancer-immunotherapy-1129/ 2025-01-22 https://www.biopharmatrend.com/news/icelandic-biotech-raises-265m-for-clinical-stage-dementia-and-skin-disease-treatments-1128/ 2025-01-22 https://www.biopharmatrend.com/news/tempus-announces-national-launch-of-ai-powered-personal-health-assistant-1127/ 2025-01-21 https://www.biopharmatrend.com/news/global-study-highlights-public-trust-in-scientists-post-pandemic-1126/ 2025-01-20 https://www.biopharmatrend.com/news/mayo-clinic-partners-with-microsoft-and-cerebras-on-radiology-and-genomics-foundation-models-1125/ 2025-01-18 https://www.biopharmatrend.com/news/rubedo-life-sciences-unveils-clinical-plans-for-rls-1496-a-gpx4-modulator-targeting-aging-and-longevity-1124/ 2025-01-18 https://www.biopharmatrend.com/news/swiss-researchers-advance-spatial-proteomics-with-ai-powered-virtual-tissue-foundation-model-1123/ 2025-01-16 https://www.biopharmatrend.com/news/baker-lab-neutralizing-snake-venom-with-ai-designed-miniproteins-1122/ 2025-01-16 https://www.biopharmatrend.com/news/recursion-and-faro-health-partner-to-reimagine-clinical-trial-design-with-ai-1121/ 2025-01-16 https://www.biopharmatrend.com/news/servier-google-cloud-extend-partnership-to-accelerate-drug-development-with-ai-1120/ 2025-01-16 https://www.biopharmatrend.com/news/lupa-raises-4m-to-modernize-veterinary-care-with-ai-1119/ 2025-01-16 https://www.biopharmatrend.com/news/proscia-grows-with-24-million-patients-diagnosed-via-ai-pathology-1118/ 2025-01-15 https://www.biopharmatrend.com/news/ai-driven-analysis-optimizes-clinical-strategy-for-a28s-liver-cancer-peptide-therapy-1117/ 2025-01-15 https://www.biopharmatrend.com/news/umoja-secures-100m-for-in-vivo-car-t-therapies-1116/ 2025-01-15 https://www.biopharmatrend.com/news/eli-lilly-acquires-scorpion-therapeutics-oncology-program-for-25-billion-1114/ 2025-01-14 https://www.biopharmatrend.com/news/vevo-therapeutics-plans-to-open-source-the-worlds-largest-single-cell-drug-response-atlas-1113/ 2025-01-14 https://www.biopharmatrend.com/news/bioptimus-reaches-76m-milestone-as-it-prepares-for-next-gen-ai-foundation-model-1112/ 2025-01-14 https://www.biopharmatrend.com/news/abcellera-expands-collaboration-with-abbvie-to-develop-novel-t-cell-engagers-for-oncology-1111/ 2025-01-14 https://www.biopharmatrend.com/news/abbvie-partners-with-simcere-on-t-cell-engager-for-multiple-myeloma-in-1b-deal-1110/ 2025-01-13 https://www.biopharmatrend.com/news/truveta-raises-320m-to-sequence-10m-exomes-and-build-largest-genetic-database-1109/ 2025-01-13 https://www.biopharmatrend.com/news/gilead-strikes-17b-deal-with-leo-pharma-for-oral-stat6-therapies-in-inflammatory-diseases-1108/ 2025-01-13 https://www.biopharmatrend.com/news/bayers-cell-therapy-for-replacing-dopamine-neurons-in-parkinsons-advances-to-phase-iii-1107/ 2025-01-13 https://www.biopharmatrend.com/news/merck-partners-with-atropos-health-to-accelerate-real-world-evidence-generation-1106/ 2025-01-11 https://www.biopharmatrend.com/news/sanas-hip-technology-enables-islet-cell-transplants-without-immunosuppression-1105/ 2025-01-11 https://www.biopharmatrend.com/news/verdiva-bio-launches-with-411m-to-propel-weekly-dosed-glp-1-obesity-drug-1104/ 2025-01-11 https://www.biopharmatrend.com/news/insilico-medicine-licenses-second-ai-generated-cancer-drug-candidate-in-a-550m-deal-1103/ 2025-01-10 https://www.biopharmatrend.com/news/eli-lilly-partners-with-uks-alchemab-to-develop-new-als-antibodies-1102/ 2025-01-09 https://www.biopharmatrend.com/business-intelligence/what-cros-cite-as-their-top-clinical-trial-challenges-and-how-they-plan-to-overcome-them-in-2025/ 2025-01-09 https://www.biopharmatrend.com/news/discovery-of-novel-longevity-therapeutics-targeting-mitochondrial-enzymes-1100/ 2025-01-09 https://www.biopharmatrend.com/news/merck-kgaa-adopts-quris-ais-organ-on-chip-platform-for-preclinical-drug-safety-testing-1099/ 2025-01-09 https://www.biopharmatrend.com/news/postera-and-pfizer-expand-610m-partnership-for-ai-driven-adc-development-1098/ 2025-01-08 https://www.biopharmatrend.com/news/tempus-and-genialis-partner-on-rna-based-biomarker-algorithms-1097/ 2025-01-08 https://www.biopharmatrend.com/news/novo-nordisk-and-valo-health-expand-ai-collaboration-for-cardiometabolic-drug-discovery-1096/ 2025-01-08 https://www.biopharmatrend.com/news/recursion-advances-two-investigational-oncology-drugs-to-clinical-trials-1095/ 2025-01-07 https://www.biopharmatrend.com/news/neumoras-kappa-opioid-antagonist-falters-in-phase-3-depression-trial-1094/ 2025-01-07 https://www.biopharmatrend.com/news/profluent-unveils-ai-model-to-advance-crispr-cas-systems-for-gene-editing-1093/ 2025-01-07 https://www.biopharmatrend.com/news/calicos-fosigotifator-falls-short-in-als-trial-1092/ 2025-01-07 https://www.biopharmatrend.com/news/insilico-medicine-reports-positive-results-from-phase-i-trials-of-ism5411-an-ai-designed-drug-for-inflammatory-bowel-disease-1091/ 2025-01-06 https://www.biopharmatrend.com/news/orbis-medicines-raises-90-million-for-oral-macrocycles-backed-by-novo-holdings-and-eli-lilly-1090/ 2025-01-06 https://www.biopharmatrend.com/news/james-wilsons-gemmabio-secures-34-million-to-advance-gene-therapy-1089/ 2024-12-24 https://www.biopharmatrend.com/news/irish-ai-startup-focused-on-natural-peptide-discovery-secures-42m-1088/ 2024-12-20 https://www.biopharmatrend.com/business-intelligence/chemistry-cros-at-a-crossroads-how-spirochem-is-adapting-to-market-shifts-in-2025-and-beyond/ 2024-12-20 https://www.biopharmatrend.com/news/ai-startup-sandboxaq-raises-300m-at-5b-valuation-amid-biopharma-partnerships-1085/ 2024-12-20 https://www.biopharmatrend.com/news/bioage-labs-and-novartis-ink-500m-deal-to-tackle-aging-related-diseases-1084/ 2024-12-19 https://www.biopharmatrend.com/news/expressionedits-appoints-dr-paul-bolno-as-board-chair-1083/ 2024-12-19 https://www.biopharmatrend.com/news/noetik-unveils-octo-vc-and-celleporter-to-build-foundation-models-for-spatial-biology-and-advance-cancer-immunotherapy-1079/ 2024-12-18 https://www.biopharmatrend.com/news/bristol-myers-squibb-grants-25m-for-insitros-milestone-in-als-target-discovery-1082/ 2024-12-18 https://www.biopharmatrend.com/news/sanofi-opens-call-for-proposals-for-2025-inext-awards-north-america-1081/ 2024-12-18 https://www.biopharmatrend.com/news/gameto-achieves-first-live-birth-using-egg-maturation-technology-outside-the-body-1080/ 2024-12-17 https://www.biopharmatrend.com/business-intelligence/legal-and-governance-considerations-in-ai-for-drug-discovery-new-paradigms-and-2025-outlook/ 2024-12-17 https://www.biopharmatrend.com/news/terray-therapeutics-and-gilead-sciences-partner-to-advance-ai-driven-small-molecule-drug-discovery-1077/ 2024-12-17 https://www.biopharmatrend.com/news/researchers-discover-role-of-trna-fragments-in-cancer-progression-1076/ 2024-12-16 https://www.biopharmatrend.com/news/candid-and-epimab-collaborate-to-develop-t-cell-engagers-for-autoimmune-diseases-1075/ 2024-12-16 https://www.biopharmatrend.com/news/rospa-urges-holiday-safety-amid-nhs-winter-crisis-talks-in-the-uk-1074/ 2024-12-16 https://www.biopharmatrend.com/news/beigene-enters-global-licensing-agreement-for-mat2a-inhibitor-syh2039-to-expand-solid-tumor-pipeline-1073/ 2024-12-13 https://www.biopharmatrend.com/news/evaxion-biotech-announces-proof-of-concept-for-ai-driven-cancer-vaccines-targeting-endogenous-retrovirus-tumor-antigens-1072/ 2024-12-13 https://www.biopharmatrend.com/news/elevation-oncology-licenses-synaffix-adc-technology-for-her3-adc-development-in-a-368-million-deal-1071/ 2024-12-12 https://www.biopharmatrend.com/news/relay-therapeutics-announces-updated-data-for-rly-2608-demonstrating-enhanced-efficacy-and-tolerability-in-breast-cancer-treatment-1070/ 2024-12-12 https://www.biopharmatrend.com/news/insilico-medicine-nominates-its-21st-pre-clinical-candidate-an-orally-available-nlrp3-inhibitor-for-inflammation-and-cns-diseases-1069/ 2024-12-12 https://www.biopharmatrend.com/news/xaira-therapeutics-expands-leadership-team-and-moves-to-new-headquarters-1068/ 2024-12-11 https://www.biopharmatrend.com/news/relation-therapeutics-partners-with-gsk-to-develop-treatments-for-fibrotic-diseases-and-osteoarthritis-1067/ 2024-12-11 https://www.biopharmatrend.com/news/owkin-shares-federated-learning-tool-for-secure-rna-seq-analysis-1066/ 2024-12-11 https://www.biopharmatrend.com/news/citryll-secures-85m-to-advance-monoclonal-antibody-targeting-nets-in-inflammatory-diseases-1064/ 2024-12-11 https://www.biopharmatrend.com/artificial-intelligence/breaking-barriers-in-inflammatory-bowel-disease-treatment-using-generative-ai-1063/ 2024-12-11 https://www.biopharmatrend.com/news/chroma-medicine-and-nvelop-therapeutics-merge-to-form-nchroma-bio-with-75-million-financing-1065/ 2024-12-11 https://www.biopharmatrend.com/news/dasa-launches-microbial-forensics-competition-to-enhance-uk-biosecurity-1062/ 2024-12-11 https://www.biopharmatrend.com/news/tasca-therapeutics-launches-with-52-million-to-advance-precision-oncology-1061/ 2024-12-10 https://www.biopharmatrend.com/news/dot-compliance-expands-ai-capabilities-to-transform-quality-and-compliance-in-life-sciences-1060/ 2024-12-10 https://www.biopharmatrend.com/news/cradle-achieves-8x-improved-egfr-binding-over-mercks-cetuximab-in-protein-design-challenge-1059/ 2024-12-10 https://www.biopharmatrend.com/artificial-intelligence/the-importance-of-accurate-patient-matching-for-ai-projects-1058/ 2024-12-10 https://www.biopharmatrend.com/news/aqemia-reaches-100-million-in-funding-plans-expansion-and-prepares-for-clinical-trials-1056/ 2024-12-10 https://www.biopharmatrend.com/news/recursion-reports-encouraging-interim-phase-1-data-a-selective-cdk7-inhibitor-1057/ 2024-12-09 https://www.biopharmatrend.com/news/bioage-labs-halts-strides-phase-2-trial-of-azelaprag-tirzepatide-combo-1055/ 2024-12-09 https://www.biopharmatrend.com/news/vittoria-biotherapeutics-highlights-novel-car-t-cell-therapy-approach-at-ash-2024-1054/ 2024-12-09 https://www.biopharmatrend.com/news/lantern-pharma-enrolls-first-patient-in-taiwan-for-phase-2-trial-for-never-smoker-lung-cancer-1053/ 2024-12-09 https://www.biopharmatrend.com/news/ideaya-demonstrates-preclinical-success-with-prmt5-inhibitor-ide892-1052/ 2024-12-09 https://www.biopharmatrend.com/news/cherry-biotech-publishes-research-on-advanced-skin-on-chip-model-in-microfluidics-1051/ 2024-12-06 https://www.biopharmatrend.com/news/antag-therapeutics-secures-80-million-series-a-financing-to-advance-gipr-based-obesity-therapies-1050/ 2024-12-06 https://www.biopharmatrend.com/news/ai-proteins-announces-collaboration-with-bristol-myers-squibb-for-miniprotein-therapeutics-worth-up-to-400-million-1049/ 2024-12-05 https://www.biopharmatrend.com/news/unnatural-products-announces-bridgebio-exercises-option-to-license-macrocyclic-therapeutics-for-rare-diseases-and-oncology-1048/ 2024-12-04 https://www.biopharmatrend.com/news/ge-healthcare-to-acquire-full-ownership-of-nihon-medi-physics-from-sumitomo-chemical-1047/ 2024-12-03 https://www.biopharmatrend.com/news/recursion-begins-first-in-human-trial-for-fda-cleared-ai-discovered-cancer-drug-rec-1245-1046/ 2024-12-03 https://www.biopharmatrend.com/news/insilico-medicine-celebrates-its-10th-ai-driven-drug-candidate-to-get-fda-ind-clearance-1045/ 2024-11-29 https://www.biopharmatrend.com/news/brainomix-wins-two-awards-for-ai-imaging-technology-1044/ 2024-11-29 https://www.biopharmatrend.com/news/raidium-secures-16-million-to-advance-radiology-foundation-model-1043/ 2024-11-29 https://www.biopharmatrend.com/news/wyss-institutes-inodes-team-secures-arpa-h-award-to-advance-implantable-immune-organs-for-ovarian-cancer-treatment-1042/ 2024-11-28 https://www.biopharmatrend.com/news/jimini-health-launches-with-8m-seed-funding-to-advance-mental-health-care-1041/ 2024-11-28 https://www.biopharmatrend.com/news/axsome-therapeutics-announces-positive-phase-3-results-for-axs-12-in-narcolepsy-1040/ 2024-11-28 https://www.biopharmatrend.com/news/novo-holdings-supports-135-million-funding-to-advance-adcendos-antibody-drug-conjugate-development-1034/ 2024-11-27 https://www.biopharmatrend.com/news/valence-labs-and-recursion-launch-openqdc-the-largest-public-quantum-mechanical-dataset-for-ml-research-1033/ 2024-11-27 https://www.biopharmatrend.com/news/roche-expands-cell-therapy-portfolio-with-15-billion-poseida-therapeutics-acquisition-1032/ 2024-11-27 https://www.biopharmatrend.com/news/a-new-genetic-insight-into-mitochondrial-dna-depletion-syndrome-1031/ 2024-11-27 https://www.biopharmatrend.com/news/communication-staffing-technology-the-persistent-barriers-in-clinical-trials-1038/ 2024-11-26 https://www.biopharmatrend.com/news/m42-ceo-hasan-jasem-al-nowais-calls-for-a-global-shift-toward-preventative-healthcare-1037/ 2024-11-26 https://www.biopharmatrend.com/news/lantern-pharma-expands-phase-2-harmonic-clinical-trial-to-japan-and-taiwan-1036/ 2024-11-26 https://www.biopharmatrend.com/news/cradle-raises-73m-for-gen-ai-protein-engineering-1035/ 2024-11-26 https://www.biopharmatrend.com/news/longevc-announces-investment-in-glyphic-biotechnologies-developing-single-molecule-protein-sequencing-1039/ 2024-11-25 https://www.biopharmatrend.com/news/trogenix-emerges-from-stealth-with-precision-gene-therapy-platform-to-target-aggressive-cancers-1030/ 2024-11-18 https://www.biopharmatrend.com/news/novartis-expands-radiopharmaceutical-portfolio-with-745m-deal-with-ratio-therapeutics-1029/ 2024-11-18 https://www.biopharmatrend.com/news/medable-adds-generative-ai-to-simplify-and-speed-up-clinical-trials-1028/ 2024-11-14 https://www.biopharmatrend.com/news/40000-nhs-healthcare-workers-to-get-ai-tool-that-cuts-admin-time-by-80-1027/ 2024-11-14 https://www.biopharmatrend.com/business-intelligence/survey-highlights-critical-need-for-ai-adoption-in-regulatory-affairs-amid-unsustainable-workloads/ 2024-11-14 https://www.biopharmatrend.com/business-intelligence/what-will-be-the-key-trends-in-ai-innovation-in-the-pharmaceutical-industry-in-2025/ 2024-11-14 https://www.biopharmatrend.com/news/immunai-and-teva-collaborate-to-advance-clinical-trials-in-oncology-and-immunology-1024/ 2024-11-14 https://www.biopharmatrend.com/news/envedas-ai-discovered-drug-env-294-enters-phase-1-trials-for-eczema-1023/ 2024-11-13 https://www.biopharmatrend.com/news/genesis-therapeutics-collaborates-with-nvidia-and-secures-additional-nventures-funding-to-accelerate-ai-driven-drug-discovery-1022/ 2024-11-13 https://www.biopharmatrend.com/news/recursion-unveils-openphenom-s16-a-foundation-model-for-microscopy-data-1021/ 2024-11-13 https://www.biopharmatrend.com/news/schrodinger-and-novartis-forge-23-billion-partnership-to-scale-computational-drug-discovery-1020/ 2024-11-12 https://www.biopharmatrend.com/news/recursion-unveils-new-foundation-model-for-molecular-property-prediction-1019/ 2024-11-12 https://www.biopharmatrend.com/news/ai-driven-drug-shows-promising-phase-iia-results-in-treating-fatal-lung-disease-1018/ 2024-11-12 https://www.biopharmatrend.com/news/alphafold3-goes-open-source-1017/ 2024-11-11 https://www.biopharmatrend.com/news/tempus-ai-to-acquire-ambry-genetics-for-600-million-1016/ 2024-11-11 https://www.biopharmatrend.com/news/bpgbio-presents-ai-guided-immune-modulating-therapeutics-at-sitc-2024-1015/ 2024-11-08 https://www.biopharmatrend.com/news/tango-therapeutics-shifts-focus-from-tng908-to-more-promising-cancer-drug-candidates-tng462-and-tng456-1014/ 2024-11-07 https://www.biopharmatrend.com/news/research-grid-raised-648m-to-drive-automation-in-clinical-trials-1013/ 2024-11-06 https://www.biopharmatrend.com/news/uk-life-sciences-venture-capital-outperforms-general-market-british-business-bank-report-1012/ 2024-11-06 https://www.biopharmatrend.com/news/new-ai-enhanced-architecture-for-ehds2-implementation-released-1010/ 2024-11-05 https://www.biopharmatrend.com/news/bc-platforms-unveils-platform-to-unify-eu-healthcare-data-governance-1009/ 2024-11-05 https://www.biopharmatrend.com/news/uk-government-and-oxford-nanopore-to-launch-pandemic-early-warning-system-1008/ 2024-11-05 https://www.biopharmatrend.com/artificial-intelligence/ai-is-key-to-democratizing-drug-discovery-1007/ 2024-11-05 https://www.biopharmatrend.com/news/elsevier-partners-with-pistoia-alliance-to-tackle-ai-challenges-in-drug-discovery-1006/ 2024-11-04 https://www.biopharmatrend.com/news/accenture-invests-in-1910-genetics-to-enhance-drug-discovery-with-ai-1005/ 2024-11-03 https://www.biopharmatrend.com/news/evogene-partners-with-google-cloud-to-build-ai-model-for-small-molecule-discovery-1004/ 2024-11-03 https://www.biopharmatrend.com/news/absci-and-twist-bioscience-collaborate-to-design-a-novel-antibody-with-generative-ai-1003/ 2024-11-02 https://www.biopharmatrend.com/news/novo-nordisk-foundation-launches-denmarks-first-ai-supercomputer-to-accelerate-drug-discovery-and-innovation-1002/ 2024-11-02 https://www.biopharmatrend.com/news/quris-ai-acquires-nortis-to-enhance-drug-safety-with-kidney-on-chip-tech-1001/ 2024-11-01 https://www.biopharmatrend.com/news/medable-joins-forces-with-google-cloud-to-deliver-digital-clinical-trials-technology-on-google-cloud-marketplace-1000/ 2024-11-01 https://www.biopharmatrend.com/news/archon-biosciences-raises-20m-to-develop-ai-enhanced-antibody-cages-for-new-therapeutics-998/ 2024-10-31 https://www.biopharmatrend.com/news/gene-therapy-lexeo-therapeutics-lx1001-shows-promise-for-apoe4-associated-alzheimers-disease-997/ 2024-10-31 https://www.biopharmatrend.com/news/ataraxis-ai-steps-forward-in-precision-cancer-care-with-4-million-in-seed-funding-996/ 2024-10-31 https://www.biopharmatrend.com/news/nsilico-medicine-and-sanofi-report-ai-enabled-milestone-in-drug-discovery-for-oncology-995/ 2024-10-31 https://www.biopharmatrend.com/news/iambic-therapeutics-unveils-enchant-ai-to-predict-clinical-outcomes-using-preclinical-data-994/ 2024-10-30 https://www.biopharmatrend.com/news/researchers-trace-stem-cells-31-years-after-transplant-revealing-long-term-survival-dynamics-993/ 2024-10-30 https://www.biopharmatrend.com/business-intelligence/global-pharma-rd-investments-surpass-276-billion-annually-exceeding-previous-estimates/ 2024-10-24 https://www.biopharmatrend.com/news/benchling-acquires-pipebio-to-enhance-ai-powered-antibody-discovery-991/ 2024-10-22 https://www.biopharmatrend.com/news/laverock-therapeutics-to-showcase-new-data-on-expanding-gene-silencing-platform-at-esgct-2024-989/ 2024-10-22 https://www.biopharmatrend.com/news/life-biosciences-presents-new-data-on-epigenetic-reprogramming-for-optic-neuropathies-at-aao-2024-990/ 2024-10-22 https://www.biopharmatrend.com/interviews/interview-with-rui-rui-zhang-xiang-from-medsir/ 2024-10-22 https://www.biopharmatrend.com/news/recursion-begins-phase-2-trial-for-ai-developed-non-antibiotic-treatment-for-recurrent-c-diff-infection-987/ 2024-10-22 https://www.biopharmatrend.com/news/combatting-antibiotic-resistance-global-superbug-map-supports-phage-therapy-development-986/ 2024-10-17 https://www.biopharmatrend.com/news/univercells-technologies-introduces-the-scale-x-nexo-bioreactor-for-enhanced-cell-culture-process-development-985/ 2024-10-16 https://www.biopharmatrend.com/news/british-patient-capital-invests-8m-in-nuclera-as-part-of-75m-series-c-funding-984/ 2024-10-16 https://www.biopharmatrend.com/news/first-comprehensive-human-skin-map-could-aid-in-regenerative-medicine-and-scar-prevention-983/ 2024-10-16 https://www.biopharmatrend.com/news/clockbio-secures-53m-seed-funding-decodes-genetic-atlas-of-human-rejuvenation-factors-982/ 2024-10-15 https://www.biopharmatrend.com/news/evaxions-ai-immunology-platform-gains-strong-validation-in-clinical-trials-981/ 2024-10-14 https://www.biopharmatrend.com/news/pfizer-joins-forces-with-ignition-ai-accelerator-to-boost-ai-driven-drug-discovery-in-southeast-asia-980/ 2024-10-14 https://www.biopharmatrend.com/news/xtalpis-ailux-biologics-enters-license-agreement-with-janssen-biotech-to-advance-ai-powered-biologics-discovery-979/ 2024-10-11 https://www.biopharmatrend.com/news/google-research-and-deepmind-unveil-tx-llm-a-new-language-model-for-therapeutic-development-978/ 2024-10-11 https://www.biopharmatrend.com/news/recursion-pharmaceuticals-receives-fda-clearance-for-ai-discovered-cancer-drug-trial-977/ 2024-10-11 https://www.biopharmatrend.com/news/biopharmcatalyst-launches-aiden-ai-chatbot-for-biotech-investors-975/ 2024-10-09 https://www.biopharmatrend.com/artificial-intelligence/revolutionizing-clinical-trials-the-power-and-potential-of-chatbots-in-data-analysis-974/ 2024-10-08 https://www.biopharmatrend.com/news/proscia-unveils-concentriq-embeddings-and-developer-toolkit-to-transform-ai-in-digital-pathology-972/ 2024-10-02 https://www.biopharmatrend.com/business-intelligence/even-10-minutes-matter-for-cancer-drug-discovery-study-reveals/ 2024-09-30 https://www.biopharmatrend.com/news/this-company-sets-a-new-milestone-with-worlds-first-human-graphene-brain-computer-interface-970/ 2024-09-30 https://www.biopharmatrend.com/business-intelligence/how-enterprise-architecture-is-powering-digital-transformation-in-healthcare/ 2024-09-27 https://www.biopharmatrend.com/news/cluepoints-introduces-medical-safety-review-tool-to-optimize-clinical-data-management-968/ 2024-09-27 https://www.biopharmatrend.com/news/bioage-labs-targets-obesity-with-upsized-ipo-expected-to-raise-198m-to-fund-clinical-trials-967/ 2024-09-26 https://www.biopharmatrend.com/news/immunai-and-astrazeneca-collaborate-to-optimize-oncology-clinical-trials-using-ai-driven-immune-mapping-966/ 2024-09-26 https://www.biopharmatrend.com/news/uk-based-laverock-therapeutics-expands-gene-silencing-technology-to-tackle-multiple-disease-areas-965/ 2024-09-26 https://www.biopharmatrend.com/news/healthcares-cybersecurity-crisis-a-growing-threat-amid-outdated-technology-964/ 2024-09-25 https://www.biopharmatrend.com/news/looking-back-how-etcemblys-etch-study-is-uncovering-new-cancer-targets-from-survivors-963/ 2024-09-25 https://www.biopharmatrend.com/news/generate-biomedicines-enters-1b-collaboration-with-novartis-to-advance-ai-driven-de-novo-protein-therapeutics-962/ 2024-09-24 https://www.biopharmatrend.com/news/immusoft-announces-positive-data-for-first-engineered-b-cell-therapy-in-clinical-trial-961/ 2024-09-23 https://www.biopharmatrend.com/news/imagebloom-launches-patient-recruitment-marketplace-for-clinical-trials-960/ 2024-09-23 https://www.biopharmatrend.com/news/aston-university-scientists-develop-gallium-infused-glass-nanoparticles-to-treat-osteosarcoma-959/ 2024-09-23 https://www.biopharmatrend.com/news/vortioxetine-shows-potential-in-glioblastoma-treatment-clinical-trials-planned-958/ 2024-09-21 https://www.biopharmatrend.com/news/dandelion-health-launches-ai-marketplace-merging-real-world-data-with-validated-algorithms-957/ 2024-09-20 https://www.biopharmatrend.com/news/asimov-unveils-ai-powered-aav-edge-platform-for-gene-therapy-design-and-manufacturing-954/ 2024-09-19 https://www.biopharmatrend.com/news/insilico-medicine-reports-positive-phase-iia-results-for-ai-designed-drug-targeting-idiopathic-pulmonary-fibrosis-953/ 2024-09-19 https://www.biopharmatrend.com/news/arzeda-raises-38m-to-meet-strong-market-demand-for-better-tasting-stevia-952/ 2024-09-17 https://www.biopharmatrend.com/news/ginkgo-bioworks-launches-model-api-to-democratize-access-to-biological-ai-models-951/ 2024-09-17 https://www.biopharmatrend.com/news/sirtexs-precision-radiation-spheres-gain-eu-certification-950/ 2024-09-16 https://www.biopharmatrend.com/news/eli-lilly-sells-automated-lab-to-arctoris-platform-relocates-to-oxford-949/ 2024-09-16 https://www.biopharmatrend.com/artificial-intelligence/how-artificial-intelligence-is-making-telehealth-for-stis-smarter-and-more-accessible-948/ 2024-09-12 https://www.biopharmatrend.com/news/unearthing-new-gems-genesis-and-gilead-collaborate-to-tackle-tough-drug-targets-947/ 2024-09-12 https://www.biopharmatrend.com/news/roche-plays-for-bigger-stakes-in-digital-pathology-with-expanded-ai-integration-for-cancer-diagnostics-946/ 2024-09-11 https://www.biopharmatrend.com/news/a-new-tool-to-spot-influential-healthcare-professionals-in-pharma-945/ 2024-09-11 https://www.biopharmatrend.com/news/cellino-biotech-secures-arpa-h-funding-to-advance-scalable-biomanufacturing-technology-for-regenerative-medicine-944/ 2024-09-11 https://www.biopharmatrend.com/news/scientistcom-and-evotec-partner-to-expand-access-to-advanced-drug-discovery-technologies-943/ 2024-09-10 https://www.biopharmatrend.com/news/relay-therapeutics-reports-positive-early-results-for-breast-cancer-drug-942/ 2024-09-10 https://www.biopharmatrend.com/news/biocaptiva-secures-us-patent-for-advanced-dna-extraction-technology-in-cancer-management-941/ 2024-09-10 https://www.biopharmatrend.com/news/mgi-introduces-new-cycloneseq-nanopore-sequencing-products-940/ 2024-09-09 https://www.biopharmatrend.com/news/superluminal-medicines-raises-120-million-series-a-to-advance-gpcr-targeted-drug-discovery-939/ 2024-09-09 https://www.biopharmatrend.com/interviews/interview-with-tim-smith-from-medable/ 2024-09-06 https://www.biopharmatrend.com/news/eli-lilly-partners-with-genetic-leap-in-409-million-ai-driven-drug-discovery-deal-938/ 2024-09-06 https://www.biopharmatrend.com/news/eth-zurichs-flexible-brain-probes-a-safer-twist-in-the-bci-journey-936/ 2024-09-05 https://www.biopharmatrend.com/news/proscia-expands-concentriq-platform-with-real-world-data-to-enhance-precision-medicine-935/ 2024-09-04 https://www.biopharmatrend.com/news/bioage-labs-files-for-ipo-with-focus-on-anti-aging-therapeutics-and-metabolic-diseases-934/ 2024-09-04 https://www.biopharmatrend.com/news/noetik-secures-40-million-series-a-to-accelerate-ai-driven-precision-cancer-therapies-926/ 2024-08-29 https://www.biopharmatrend.com/news/brinter-am-technologies-to-supply-3d-bioprinter-for-esas-advanced-tissue-manufacturing-on-iss-932/ 2024-08-29 https://www.biopharmatrend.com/news/novartis-phase-iii-v-mono-trial-demonstrates-efficacy-of-leqvio-in-reducing-ldl-c-in-ascvd-patients-931/ 2024-08-29 https://www.biopharmatrend.com/news/flagship-pioneering-and-quotient-therapeutics-partner-with-pfizer-to-advance-research-in-cardiovascular-and-renal-diseases-930/ 2024-08-29 https://www.biopharmatrend.com/news/bayer-and-nextrna-therapeutics-partner-to-develop-novel-small-molecule-drugs-targeting-long-non-coding-rna-in-cancer-929/ 2024-08-28 https://www.biopharmatrend.com/news/us-allocates-50-million-to-hps-microfluidics-semiconductor-fab-928/ 2024-08-28 https://www.biopharmatrend.com/news/london-biotechnology-show-makes-grand-return-to-unveil-cutting-edge-advances-in-health-medicine-927/ 2024-08-28 https://www.biopharmatrend.com/news/microbioticas-microbiome-medicines-progress-to-clinical-trials-for-melanoma-and-ulcerative-colitis-925/ 2024-08-27 https://www.biopharmatrend.com/news/lg-ai-research-introduces-exaonepath-a-specialized-model-for-histopathology-image-analysis-924/ 2024-08-23 https://www.biopharmatrend.com/news/scientists-found-a-new-epigenetic-factor-preventing-inherited-diseases-923/ 2024-08-22 https://www.biopharmatrend.com/news/piramidals-ai-transforming-neurological-diagnostics-by-decoding-brainwaves-922/ 2024-08-22 https://www.biopharmatrend.com/news/supreme-group-acquires-biostrata-921/ 2024-08-22 https://www.biopharmatrend.com/business-intelligence/biopharma-industry-ranks-high-in-employee-wellbeing-according-to-great-place-to-work-study/ 2024-08-22 https://www.biopharmatrend.com/news/reviving-the-brains-waste-disposal-system-with-a-labor-inducing-drug-919/ 2024-08-21 https://www.biopharmatrend.com/news/vandria-raises-307m-in-series-a-to-advance-mitophagy-therapy-for-neurodegenerative-diseases-918/ 2024-08-21 https://www.biopharmatrend.com/news/eli-lillys-tirzepatide-shows-promise-in-preventing-type-2-diabetes-917/ 2024-08-20 https://www.biopharmatrend.com/news/fujifilms-subsidiary-unveils-100m-microbial-fermentation-facility-in-uk-tripling-production-capacity-915/ 2024-08-20 https://www.biopharmatrend.com/next-gen-tools/thermoface-revealing-biological-age-and-hidden-health-risks-via-your-faces-heat-map-914/ 2024-08-19 https://www.biopharmatrend.com/news/blackrock-neurotech-restores-als-patients-speech-using-brain-computer-interface-913/ 2024-08-19 https://www.biopharmatrend.com/news/nanoviricides-prepares-for-phase-ii-clinical-trial-of-broad-spectrum-antiviral-nv-387-912/ 2024-08-19 https://www.biopharmatrend.com/news/walgreens-partners-with-us-government-to-advance-decentralized-clinical-trials-911/ 2024-08-19 https://www.biopharmatrend.com/news/indica-labs-introduces-halo-ai-apps-for-enhanced-life-sciences-image-analysis-909/ 2024-08-17 https://www.biopharmatrend.com/news/pathos-ai-acquires-brain-penetrant-prmt5-inhibitor-for-precision-cancer-therapy-910/ 2024-08-16 https://www.biopharmatrend.com/news/pfizer-appoints-new-chief-ai-officer-to-enhance-digital-innovation-908/ 2024-08-16 https://www.biopharmatrend.com/news/23andme-shifts-focus-to-telehealth-glp-1-prescriptions-amid-strategic-realignment-906/ 2024-08-15 https://www.biopharmatrend.com/news/medable-introduces-new-ecoa-platform-to-streamline-clinical-trial-launches-905/ 2024-08-14 https://www.biopharmatrend.com/news/basecamp-research-partners-with-cameroon-to-share-benefits-from-genetic-data-use-in-landmark-agreement-904/ 2024-08-14 https://www.biopharmatrend.com/news/veridix-ai-introduces-protocol-digitization-to-streamline-clinical-trial-study-builds-903/ 2024-08-14 https://www.biopharmatrend.com/news/openfold-consortium-expands-with-six-new-members-to-strengthen-open-source-ai-tools-for-drug-discovery-902/ 2024-08-13 https://www.biopharmatrend.com/news/ersist-ai-and-nivagen-collaborate-on-ai-enhanced-manufacturing-for-long-acting-injectables-901/ 2024-08-13 https://www.biopharmatrend.com/news/halda-therapeutics-secures-126-million-in-series-b-extension-to-advance-riptac-cancer-therapies-900/ 2024-08-12 https://www.biopharmatrend.com/news/introducing-ai-framework-for-detecting-llm-hallucinations-in-medical-summaries-899/ 2024-08-11 https://www.biopharmatrend.com/news/roche-arguably-weighs-sale-of-its-health-data-subsidiary-amid-strategic-challenges-a-19-billion-gamble-in-question-898/ 2024-08-11 https://www.biopharmatrend.com/news/tampa-general-hospital-implements-ai-powered-platform-to-improve-operating-room-efficiency-897/ 2024-08-09 https://www.biopharmatrend.com/news/blood-proteins-provide-new-insights-into-biological-aging-and-disease-risk-896/ 2024-08-09 https://www.biopharmatrend.com/news/insilico-medicines-ai-designed-tead-inhibitor-receives-ind-approval-and-orphan-drug-designation-from-fda-895/ 2024-08-09 https://www.biopharmatrend.com/news/recursion-pharmaceuticals-acquires-exscientia-in-688-million-all-stock-deal-894/ 2024-08-08 https://www.biopharmatrend.com/news/rollout-of-the-first-ever-blood-test-for-alzheimers-detection-by-unilabs-and-c2n-diagnostics-893/ 2024-08-08 https://www.biopharmatrend.com/news/cell-microsystems-introduces-lab-services-for-cell-line-and-organoid-development-892/ 2024-08-08 https://www.biopharmatrend.com/news/3d-printed-blood-vessels-edge-us-closer-to-artificial-organs-891/ 2024-08-08 https://www.biopharmatrend.com/business-intelligence/how-to-achieve-successful-digital-transformation-in-healthcare/ 2024-08-06 https://www.biopharmatrend.com/news/riverlane-secures-75m-for-quantum-error-correction-technology-889/ 2024-08-06 https://www.biopharmatrend.com/news/ucla-health-initiates-clinical-trial-for-personalized-cancer-vaccine-targeting-aggressive-brain-tumors-in-youth-888/ 2024-08-06 https://www.biopharmatrend.com/news/lantern-pharma-reports-86-clinical-benefit-in-nsclc-trial-887/ 2024-08-05 https://www.biopharmatrend.com/business-intelligence/defining-intelligence-and-consciousness-a-collaborative-effort-for-consensus-in-diverse-intelligent-systems/ 2024-08-02 https://www.biopharmatrend.com/news/this-company-democratizes-cancer-research-by-open-sourcing-ai-foundation-model-for-pathology-885/ 2024-08-01 https://www.biopharmatrend.com/news/healx-secures-47-million-in-series-c-funding-to-advance-rare-disease-treatments-884/ 2024-08-01 https://www.biopharmatrend.com/news/montara-therapeutics-secures-8-million-to-advance-brain-targeting-drug-platform-883/ 2024-07-31 https://www.biopharmatrend.com/news/polaroid-therapeutics-and-sfm-limited-collaborate-to-combat-antimicrobial-resistance-in-wound-care-882/ 2024-07-30 https://www.biopharmatrend.com/news/engineered-toxoplasma-used-for-brain-therapeutic-delivery-880/ 2024-07-30 https://www.biopharmatrend.com/news/off-the-shelf-stem-cell-therapy-reduces-pain-by-58-regenerates-cartilage-879/ 2024-07-29 https://www.biopharmatrend.com/news/ai-biotech-bioage-initiates-strides-phase-2-clinical-trial-for-obesity-treatment-878/ 2024-07-29 https://www.biopharmatrend.com/news/d-waves-new-aiml-quantum-cloud-service-roadmap-implications-for-drug-discovery-877/ 2024-07-29 https://www.biopharmatrend.com/news/4d-medicine-secures-34m-to-advance-resorbable-biomaterial-technology-876/ 2024-07-25 https://www.biopharmatrend.com/news/advarra-centralizes-clinical-trial-patient-recruitment-to-enhance-enrollment-efficiency-875/ 2024-07-24 https://www.biopharmatrend.com/news/insilico-medicine-unveils-ai-assistant-for-medical-research-drafting-873/ 2024-07-24 https://www.biopharmatrend.com/news/touchlight-and-gsk-partner-for-enzymatic-dbdna-production-in-mrna-manufacturing-874/ 2024-07-24 https://www.biopharmatrend.com/interviews/the-synergistic-potential-of-ai-and-synthetic-biology-interview-with-sp-globals-miriam-fernandez/ 2024-07-23 https://www.biopharmatrend.com/news/abiologics-introduces-synteins-a-new-biotherapeutic-class-for-advanced-disease-treatment-871/ 2024-07-23 https://www.biopharmatrend.com/news/proscia-introduces-enhanced-concentriq-ap-with-multi-ai-workflows-for-pathology-870/ 2024-07-23 https://www.biopharmatrend.com/news/new-insurance-model-could-transform-clinical-trial-financing-869/ 2024-07-22 https://www.biopharmatrend.com/business-intelligence/reflecting-on-the-first-half-of-2024/ 2024-07-22 https://www.biopharmatrend.com/news/liquid-biopsy-methodology-for-monitoring-metastatic-prostate-cancer-868/ 2024-07-22 https://www.biopharmatrend.com/biotech-ventures/10-notable-biotech-companies-with-recent-major-funding-rounds-867/ 2024-07-19 https://www.biopharmatrend.com/news/blocking-il-11-protein-increases-lifespan-in-mice-865/ 2024-07-19 https://www.biopharmatrend.com/news/artiva-biotherapeutics-lowers-ipo-price-raises-167-million-for-autoimmune-therapies-864/ 2024-07-19 https://www.biopharmatrend.com/news/skycell-and-validaide-partner-to-enhance-pharmaceutical-supply-chain-efficiency-863/ 2024-07-19 https://www.biopharmatrend.com/news/integra-therapeutics-secures-105-million-from-european-commission-for-ficat-advanced-therapies-platform-862/ 2024-07-18 https://www.biopharmatrend.com/news/brainomix-and-boehringer-ingelheim-partner-to-enhance-diagnosis-and-treatment-of-fibrosing-lung-disease-861/ 2024-07-18 https://www.biopharmatrend.com/news/genentech-ends-shp2-inhibitor-collaboration-with-relay-therapeutics-860/ 2024-07-17 https://www.biopharmatrend.com/news/cytoreason-secures-80-million-to-advance-ai-disease-models-859/ 2024-07-17 https://www.biopharmatrend.com/news/evaxion-biotech-showcases-enhanced-ai-immunologytm-capabilities-at-ismb-2024-858/ 2024-07-16 https://www.biopharmatrend.com/news/synchron-integrates-generative-ai-with-brain-computer-interface-software-857/ 2024-07-15 https://www.biopharmatrend.com/neurotech/beyond-neuralink-the-diverse-landscape-of-brain-computer-interfaces-856/ 2024-07-15 https://www.biopharmatrend.com/news/oxford-drug-design-validates-novel-oncology-therapeutic-mechanism-855/ 2024-07-12 https://www.biopharmatrend.com/news/bioptimus-introduces-h-optimus-0-an-open-source-ai-model-for-pathology-854/ 2024-07-12 https://www.biopharmatrend.com/next-gen-tools/element-biosciences-secures-277-million-to-expand-innovative-sequencing-and-multi-omics-technologies-853/ 2024-07-11 https://www.biopharmatrend.com/news/gene-editing-tool-modifies-gut-bacteria-in-living-mice-852/ 2024-07-11 https://www.biopharmatrend.com/news/lantern-pharma-advances-development-of-molecular-diagnostic-for-oncology-clinical-trials-851/ 2024-07-11 https://www.biopharmatrend.com/news/concr-launches-vision-trial-using-digital-twins-for-predicting-breast-cancer-outcomes-850/ 2024-07-10 https://www.biopharmatrend.com/news/advances-in-lbp-manufacturing-microbiotica-and-biose-industrie-prepare-for-clinical-studies-849/ 2024-07-09 https://www.biopharmatrend.com/news/biostate-ai-launches-rna-sequencing-and-data-analysis-services-848/ 2024-07-09 https://www.biopharmatrend.com/news/innovative-light-weight-microscope-captures-large-scale-brain-activity-in-freely-moving-mice-847/ 2024-07-09 https://www.biopharmatrend.com/news/myricx-bio-secures-90m-series-a-funding-to-progress-nmti-adc-therapeutics-into-clinical-trials-846/ 2024-07-08 https://www.biopharmatrend.com/news/fda-approves-signet-therapeutics-ind-application-for-sigx1094-in-diffuse-gastric-cancer-845/ 2024-07-05 https://www.biopharmatrend.com/news/omny-health-partners-with-quanthealth-and-arisglobal-to-enhance-ai-driven-healthcare-solutions-843/ 2024-07-03 https://www.biopharmatrend.com/news/aptamer-group-partners-with-astrazeneca-to-explore-optimer-vehicles-for-sirna-delivery-844/ 2024-07-03 https://www.biopharmatrend.com/news/waypoint-bio-secures-145-million-to-advance-drug-discovery-with-innovative-in-vivo-spatial-pooled-screening-technology-842/ 2024-07-01 https://www.biopharmatrend.com/business-intelligence/a-booming-anti-obesity-drug-discovery-landscape-at-a-glance-with-challenges/ 2024-06-27 https://www.biopharmatrend.com/news/new-dna-editing-technique-offers-potential-for-advanced-genome-engineering-840/ 2024-06-27 https://www.biopharmatrend.com/news/formation-bio-secures-372-million-series-d-funding-for-ai-driven-drug-development-839/ 2024-06-26 https://www.biopharmatrend.com/news/evaxion-biotech-receives-positive-feedback-on-patent-application-for-personalized-vaccine-targets-838/ 2024-06-26 https://www.biopharmatrend.com/news/evolutionaryscale-unveils-esm3-generative-ai-model-for-advanced-protein-design-837/ 2024-06-25 https://www.biopharmatrend.com/news/cromatic-launches-ai-powered-sourcerer-for-streamlined-rd-outsourcing-in-life-sciences-836/ 2024-06-24 https://www.biopharmatrend.com/news/this-company-anonymized-18-trillion-records-to-support-biomedical-research-834/ 2024-06-19 https://www.biopharmatrend.com/business-intelligence/fhi-newscast-at-hlth-europe-conference/ 2024-06-18 https://www.biopharmatrend.com/news/basecamp-research-introduces-zymctrl-an-open-source-ai-tool-for-enzyme-design-832/ 2024-06-18 https://www.biopharmatrend.com/news/enveda-biosciences-secures-55-million-to-accelerate-drug-discovery-efforts-831/ 2024-06-17 https://www.biopharmatrend.com/news/yonalink-completes-largest-ehr-to-edc-data-transfer-pilot-in-clinical-trials-830/ 2024-06-17 https://www.biopharmatrend.com/news/santa-ana-bio-secures-168-million-to-propel-precision-medicine-for-inflammatory-diseases-829/ 2024-06-14 https://www.biopharmatrend.com/interviews/pioneering-the-largest-foundation-model-to-transform-rna-research-an-interview-with-brendan-frey/ 2024-06-13 https://www.biopharmatrend.com/news/quantumpharm-xtalpi-begins-trading-on-hong-kong-stock-exchange-827/ 2024-06-13 https://www.biopharmatrend.com/news/cytomos-launches-benchtop-cell-analyzer-826/ 2024-06-12 https://www.biopharmatrend.com/news/lantern-pharma-receives-japanese-patent-for-oncology-drug-candidate-lp-284-825/ 2024-06-12 https://www.biopharmatrend.com/news/lokavant-introduces-ai-solution-for-comprehensive-clinical-trial-optimization-824/ 2024-06-11 https://www.biopharmatrend.com/news/new-lensai-api-by-biostrand-integrates-large-language-models-with-health-data-for-advanced-drug-development-823/ 2024-06-10 https://www.biopharmatrend.com/next-gen-tools/the-rise-of-cyclic-peptides-bridging-the-gap-in-modern-medicine-822/ 2024-06-09 https://www.biopharmatrend.com/news/envisagenics-secures-25-million-series-b-funding-to-advance-rna-splicing-therapeutics-821/ 2024-06-06 https://www.biopharmatrend.com/news/fda-and-cluepoints-extend-collaboration-to-enhance-clinical-trial-data-integrity-with-ai-and-machine-learning-820/ 2024-06-06 https://www.biopharmatrend.com/news/nobel-laureate-inaugurates-new-molecular-devices-facility-for-manufacturing-patient-derived-organoids-819/ 2024-06-05 https://www.biopharmatrend.com/news/merck-kgaa-partners-with-biolojic-design-for-376m-antibody-drug-conjugate-development-818/ 2024-06-04 https://www.biopharmatrend.com/news/paige-introduces-multi-modal-ai-models-for-enhanced-precision-oncology-and-drug-discovery-817/ 2024-06-03 https://www.biopharmatrend.com/news/insmed-announces-positive-results-from-aspen-study-of-brensocatib-in-bronchiectasis-patients-816/ 2024-05-30 https://www.biopharmatrend.com/news/expressionedits-raises-13m-for-ai-based-protein-expression-technology-815/ 2024-05-29 https://www.biopharmatrend.com/news/deepcure-unveils-ai-driven-chemical-synthesis-platform-814/ 2024-05-28 https://www.biopharmatrend.com/news/owkin-expands-oncology-pipeline-with-ai-and-ep2ep4-dual-inhibitor-from-idorsia-813/ 2024-05-23 https://www.biopharmatrend.com/news/tempus-ai-files-s-1-registration-to-go-public-811/ 2024-05-22 https://www.biopharmatrend.com/news/sanofi-formation-bio-and-openai-partner-to-innovate-drug-development-with-ai-810/ 2024-05-22 https://www.biopharmatrend.com/news/labgenius-secures-35-million-to-enhance-ml-driven-antibody-discovery-809/ 2024-05-21 https://www.biopharmatrend.com/news/insilico-medicine-unveils-nach0-a-comprehensive-llm-for-chemical-and-biomedical-applications-808/ 2024-05-21 https://www.biopharmatrend.com/news/astrazeneca-to-establish-15-billion-adc-manufacturing-facility-in-singapore-807/ 2024-05-20 https://www.biopharmatrend.com/news/accentures-investment-in-turbine-enhances-ai-powered-cell-simulations-for-biopharma-rd-806/ 2024-05-17 https://www.biopharmatrend.com/news/insilico-medicine-initiates-phase-i-clinical-trial-for-novel-qpctl-inhibitor-805/ 2024-05-17 https://www.biopharmatrend.com/news/veranova-and-phorumai-partner-to-deliver-generative-ai-chemistry-optimization-to-the-pharmaceutical-biotech-industry-804/ 2024-05-16 https://www.biopharmatrend.com/news/karius-gains-100m-and-fda-breakthrough-designation-for-genomic-pneumonia-test-803/ 2024-05-16 https://www.biopharmatrend.com/news/sartorius-and-nvidia-to-develop-ai-models-for-stem-cell-derived-organoids-reducing-animal-testing-in-drug-discovery-802/ 2024-05-16 https://www.biopharmatrend.com/news/nabla-bio-advances-generative-protein-design-with-26m-series-a-funding-801/ 2024-05-15 https://www.biopharmatrend.com/news/recursion-unveils-biohive-2-fastest-pharma-owned-supercomputer-800/ 2024-05-14 https://www.biopharmatrend.com/news/troubling-safety-data-overshadows-efficacy-in-macrogenics-phase-2-study-799/ 2024-05-13 https://www.biopharmatrend.com/next-gen-tools/4-biotech-startups-developing-breakthrough-drug-modalities-798/ 2024-05-09 https://www.biopharmatrend.com/news/deepmind-launches-advanced-alphafold-model-to-enhance-drug-discovery-797/ 2024-05-08 https://www.biopharmatrend.com/artificial-intelligence/the-growing-impact-of-ai-in-healthcare-703/ 2024-05-03 https://www.biopharmatrend.com/news/cytomos-to-unveil-celledoniatm-technology-at-london-biotechnology-show-2024-796/ 2024-05-03 https://www.biopharmatrend.com/news/insilico-medicine-relocates-headquarters-to-cambridge-massachusetts-794/ 2024-05-02 https://www.biopharmatrend.com/business-intelligence/ai-for-treating-rare-disease/ 2024-04-29 https://www.biopharmatrend.com/artificial-intelligence/optimising-drug-discovery-rd-with-graphs-792/ 2024-04-29 https://www.biopharmatrend.com/interviews/interview-with-stef-van-grieken-from-cradle/ 2024-04-26 https://www.biopharmatrend.com/news/xaira-therapeutics-launches-with-over-1-billion-to-enhance-drug-rd-using-ai-791/ 2024-04-23 https://www.biopharmatrend.com/news/gpt-rubedo-life-sciences-garners-40m-to-advance-clinical-trials-in-age-related-diseases-790/ 2024-04-22 https://www.biopharmatrend.com/interviews/interview-with-leonid-stoianov-from-trialize/ 2024-04-18 https://www.biopharmatrend.com/business-intelligence/organ-on-chips-advance-to-industry-a-comprehensive-report-2024/ 2024-04-17 https://www.biopharmatrend.com/news/healthcare-industry-faces-cybersecurity-mismatch-according-to-krolls-latest-report-787/ 2024-04-17 https://www.biopharmatrend.com/news/isospec-analytics-secures-19-million-to-advance-biomolecular-identification-technology-786/ 2024-04-16 https://www.biopharmatrend.com/news/seed-health-unveils-coda-pioneering-computational-biology-platform-for-microbiome-research-783/ 2024-04-13 https://www.biopharmatrend.com/interviews/a-closer-look-at-elseviers-ai-strategy-in-drug-discovery/ 2024-04-12 https://www.biopharmatrend.com/artificial-intelligence/how-ai-empowers-biomarker-driven-clinical-trials-705/ 2024-04-08 https://www.biopharmatrend.com/artificial-intelligence/patented-ai-platform-identifies-promising-early-stage-biopharma-assets-and-companies-781/ 2024-04-08 https://www.biopharmatrend.com/neurotech/navigating-the-brain-computer-interface-frontier-an-interview-with-ex-nasa-expert-780/ 2024-04-07 https://www.biopharmatrend.com/news/new-landmark-report-unveils-a-decade-of-ai-transformation-in-drug-discovery-779/ 2024-04-03 https://www.biopharmatrend.com/business-intelligence/ai-drug-discovery-pipelines/ 2024-04-03 https://www.biopharmatrend.com/business-intelligence/case-studies/revolutionizing-clinical-trials-how-ai-and-automation-reduced-study-build-time-from-months-to-days/ 2024-04-01 https://www.biopharmatrend.com/news/ai-integration-advances-lung-fibrosis-patient-stratification-in-clinical-trials-777/ 2024-03-27 https://www.biopharmatrend.com/news/nvidia-introduces-new-software-tools-for-biopharma-ai-applications-775/ 2024-03-19 https://www.biopharmatrend.com/news/denmark-collaborates-with-nvidia-to-establish-ai-innovation-centre-featuring-advanced-supercomputer-774/ 2024-03-19 https://www.biopharmatrend.com/business-intelligence/case-studies/ai-becomes-a-drop-in-replacement-for-docking-with-artidock-20/ 2024-03-19 https://www.biopharmatrend.com/business-intelligence/lucrative-opportunities-in-half-a-trillion-neuroscience-market-trends-and-top-companies-to-follow/ 2024-03-18 https://www.biopharmatrend.com/news/basecamp-research-introduces-basefold-enhancing-accuracy-in-protein-structure-prediction-772/ 2024-03-14 https://www.biopharmatrend.com/business-intelligence/11-biopharma-trends-to-watch-in-2024/ 2024-03-14 https://www.biopharmatrend.com/news/recursion-expands-its-presence-with-a-new-london-office-and-expands-scientific-advisory-team-770/ 2024-03-11 https://www.biopharmatrend.com/next-gen-tools/a-leap-into-the-future-fda-greenlights-transformative-advances-in-robotic-surgery-769/ 2024-03-06 https://www.biopharmatrend.com/news/elsevier-and-iktos-collaborate-to-enhance-drug-discovery-with-ai-enhanced-chemistry-database-768/ 2024-03-05 https://www.biopharmatrend.com/news/ai-driven-oncology-platform-aims-for-100-billion-data-points-milestone-in-2024-for-advanced-drug-discovery-and-treatment-combinations-767/ 2024-03-04 https://www.biopharmatrend.com/news/sam-altman-backed-startup-partners-with-microsoft-to-enable-the-ai-infrastructure-for-drug-discovery-748/ 2024-02-29 https://www.biopharmatrend.com/news/ginkgo-bioworks-acquires-3-startups-and-launches-a-technology-network-of-25-more-in-a-single-day-766/ 2024-02-28 https://www.biopharmatrend.com/news/curve-therapeutics-secures-another-10-million-for-its-intracellular-screening-platform-765/ 2024-02-28 https://www.biopharmatrend.com/artificial-intelligence/8-startups-applying-quantum-calculations-for-drug-discovery-99/ 2024-02-24 https://www.biopharmatrend.com/next-gen-tools/this-company-makes-quantum-computing-actually-useful-764/ 2024-02-24 https://www.biopharmatrend.com/interviews/how-precision-neuroscience-and-drug-synergies-could-revolutionize-neurology/ 2024-02-23 https://www.biopharmatrend.com/news/using-quantum-enhanced-ai-to-design-novel-kras-inhibitors-762/ 2024-02-22 https://www.biopharmatrend.com/news/a-novel-cancer-therapy-targeting-kif18a-with-ai-designed-compound-761/ 2024-02-21 https://www.biopharmatrend.com/news/absci-initiates-ind-enabling-studies-for-abs-101-aiming-for-enhanced-anti-tl1a-antibody-therapy-760/ 2024-02-21 https://www.biopharmatrend.com/news/accelerating-drug-discovery-at-receptorai-with-nvidia-bionemo-cloud-apis-759/ 2024-02-19 https://www.biopharmatrend.com/news/ultima-genomics-launches-ug-100tm-sequencer-to-advance-affordable-genomic-sequencing-757/ 2024-02-07 https://www.biopharmatrend.com/news/exscientia-launches-new-clinical-study-to-enhance-cancer-treatment-through-ai-756/ 2024-02-07 https://www.biopharmatrend.com/interviews/navigating-protein-designs-next-wave-with-elise-de-reus-from-cradle/ 2024-02-06 https://www.biopharmatrend.com/interviews/what-drives-dubais-health-tech-boom/ 2024-02-06 https://www.biopharmatrend.com/business-intelligence/innovators-dilemma-in-biotech/ 2024-02-05 https://www.biopharmatrend.com/news/aqemia-raises-60m-in-series-a-funding-to-advance-ai-driven-drug-discovery-752/ 2024-02-02 https://www.biopharmatrend.com/news/monomer-bio-raises-56-million-to-advance-laboratory-automation-in-drug-discovery-751/ 2024-01-31 https://www.biopharmatrend.com/news/neuralink-claims-first-successful-human-brain-implant-750/ 2024-01-30 https://www.biopharmatrend.com/business-intelligence/how-modern-biotechnology-is-shaping-our-future/ 2024-01-30 https://www.biopharmatrend.com/news/mayo-clinics-stem-cell-research-takes-to-space-747/ 2024-01-28 https://www.biopharmatrend.com/artificial-intelligence/10-companies-applying-ai-for-biologics-discovery-590/ 2024-01-26 https://www.biopharmatrend.com/biotech-ventures/a-look-at-five-promising-biotech-ipos-in-2024-746/ 2024-01-26 https://www.biopharmatrend.com/next-gen-tools/a-journey-from-organ-on-a-chip-to-patient-on-a-chip-towards-personalized-medicine-695/ 2024-01-25 https://www.biopharmatrend.com/news/this-collaboration-aims-to-achieve-infinite-recyclability-of-plastics-745/ 2024-01-25 https://www.biopharmatrend.com/interviews/interview-with-panna-sharma/ 2024-01-23 https://www.biopharmatrend.com/business-intelligence/case-studies/busting-the-posebuster-v3-ai-docking-software-artidock-beats-industrys-state-of-the-art-in-speed-and-accuracy/ 2024-01-18 https://www.biopharmatrend.com/news/in-an-industry-first-veeva-migrates-entire-study-portfolio-to-vault-edc-741/ 2024-01-17 https://www.biopharmatrend.com/news/innovative-approach-to-combat-arthritis-mesenbios-stem-cell-therapy-739/ 2024-01-15 https://www.biopharmatrend.com/post/546-predicting-a-patients-future-with-a-crystal-ball-comprised-of-cell-free-dna/ 2024-01-12 https://www.biopharmatrend.com/news/a-proof-of-concept-study-towards-novel-als-therapy-737/ 2024-01-12 https://www.biopharmatrend.com/news/xcell-biosciences-and-elevatebio-forge-partnership-to-enhance-cell-and-gene-therapy-development-736/ 2024-01-11 https://www.biopharmatrend.com/post/730-life-sciences-net-zero-charting-a-sustainable-path/ 2024-01-11 https://www.biopharmatrend.com/interviews/enabling-pharma-40-using-ai-interview-with-rajiv-anand-founder-of-quarticai/ 2024-01-11 https://www.biopharmatrend.com/news/mit-unveils-breakthrough-technique-for-noninvasive-rna-expression-studies-734/ 2024-01-10 https://www.biopharmatrend.com/news/arguably-the-worlds-first-real-time-pathogen-detection-device-733/ 2024-01-09 https://www.biopharmatrend.com/news/isomorphic-labs-announces-collaborations-with-eli-lilly-and-novartis-for-ai-driven-drug-discovery-732/ 2024-01-07 https://www.biopharmatrend.com/news/exploring-a-novel-approach-to-treat-primary-ciliary-dyskinesia-the-rct1100-study-731/ 2024-01-06 https://www.biopharmatrend.com/artificial-intelligence/7-notable-ai-companies-in-clinical-research-to-watch-in-2020-243/ 2024-01-05 https://www.biopharmatrend.com/news/menarini-group-and-insilico-medicine-forge-partnership-for-novel-cancer-therapy-development-729/ 2024-01-04 https://www.biopharmatrend.com/news/c4x-discovery-advancing-drug-discovery-with-nrf2-activator-program-728/ 2024-01-04 https://www.biopharmatrend.com/news/invivo-biosystems-raises-3m-for-crispr-research-and-welcomes-new-board-chairman-727/ 2024-01-03 https://www.biopharmatrend.com/news/bioptimus-pioneering-llm-technology-in-biotechnology-726/ 2024-01-03 https://www.biopharmatrend.com/artificial-intelligence/ai-breaches-the-barrier-towards-better-cns-drug-discovery-704/ 2023-12-28 https://www.biopharmatrend.com/news/bristol-myers-squibb-acquires-rayzebio-in-a-strategic-move-to-expand-radiopharmaceutical-capabilities-723/ 2023-12-28 https://www.biopharmatrend.com/next-gen-tools/the-rising-popularity-of-antibody-drug-conjugates-in-cancer-treatment-with-challenges-721/ 2023-12-26 https://www.biopharmatrend.com/news/c4-therapeutics-and-merck-collaborate-on-innovative-cancer-treatment-720/ 2023-12-26 https://www.biopharmatrend.com/news/legochem-biosciences-strikes-licensing-deal-with-janssen-for-adc-development-719/ 2023-12-26 https://www.biopharmatrend.com/business-intelligence/addressing-inequity-in-medicinal-research-the-need-to-expand-genomic-databases/ 2023-12-20 https://www.biopharmatrend.com/news/unnatural-products-secures-32m-to-advance-drug-development-with-ai-enhanced-macrocycles-717/ 2023-12-20 https://www.biopharmatrend.com/news/sisaf-advances-in-alopecia-treatment-with-phase-ii-trial-of-bio-courier-technology-716/ 2023-12-18 https://www.biopharmatrend.com/news/vandria-gains-momentum-with-206m-funding-to-propel-novel-cns-and-mitochondrial-therapies-715/ 2023-12-18 https://www.biopharmatrend.com/news/acsr-partners-with-proscia-to-accelerate-global-hiv-cancer-research-through-advanced-digital-pathology-platform-714/ 2023-12-18 https://www.biopharmatrend.com/business-intelligence/case-studies/artidock-from-receptorai-next-generation-ai-docking-that-beats-diffdock-and-alphafold-latest/ 2023-12-05 https://www.biopharmatrend.com/business-intelligence/insilico-medicines-generative-ai-patent-provides-advantage-in-ai-drug-discovery-race/ 2023-11-17 https://www.biopharmatrend.com/artificial-intelligence/eight-approaches-to-leveraging-ai-in-clinical-trials-with-the-key-industry-innovators-691/ 2023-11-07 https://www.biopharmatrend.com/business-intelligence/becoming-pharma-40-how-digital-transformation-is-reshaping-pharmaceuticals/ 2023-11-07 https://www.biopharmatrend.com/business-intelligence/will-small-molecules-sustain-pharmaceutical-race-with-biologics/ 2023-11-03 https://www.biopharmatrend.com/interviews/interview-with-fareed-melhem-from-medidata-ai/ 2023-10-29 https://www.biopharmatrend.com/business-intelligence/how-lithuanias-deep-tech-ecosystem-is-fueling-the-countrys-life-sciences-boom/ 2023-10-06 https://www.biopharmatrend.com/interviews/interview-with-markus-gershater-from-synthace/ 2023-09-22 https://www.biopharmatrend.com/interviews/interview-with-abigail-kukura/ 2023-09-13 https://www.biopharmatrend.com/interviews/interview-with-michael-seminerio/ 2023-09-03 https://www.biopharmatrend.com/business-intelligence/navigating-the-uk-health-technology-market-trends-and-opportunities/ 2023-08-16 https://www.biopharmatrend.com/business-intelligence/the-evolving-pharma-rd-outsourcing-industry-a-birds-eye-view/ 2023-08-01 https://www.biopharmatrend.com/business-intelligence/pharmaceutical-artificial-intelligence-key-developments-in-2022/ 2023-07-26 https://www.biopharmatrend.com/next-gen-tools/the-explosion-of-therapeutic-modalities-small-molecules-biologics-and-everything-in-between-402/ 2023-07-14 https://www.biopharmatrend.com/business-intelligence/pharma-rd-outsourcing-is-on-the-rise/ 2023-07-11 https://www.biopharmatrend.com/interviews/interview-with-eduardo-abeliuk-ceo-at-teselagen/ 2023-07-10 https://www.biopharmatrend.com/artificial-intelligence/how-ai-driven-multi-omics-for-drug-discovery-is-reshaping-medicine-696/ 2023-06-21 https://www.biopharmatrend.com/news/vrg50635-a-drug-discovered-through-verge-genomics-ai-powered-planform-shows-promising-phase-1-results-for-als-treatment-697/ 2023-06-20 https://www.biopharmatrend.com/business-intelligence/how-to-discover-a-preclinical-drug-candidate-in-two-years/ 2023-06-18 https://www.biopharmatrend.com/news/iggenix-advances-therapeutic-approach-to-peanut-allergies-with-igg4-monoclonal-antibodies-692/ 2023-06-16 https://www.biopharmatrend.com/interviews/dr-james-field-on-breaking-the-cognition-barrier-in-antibody-discovery-with-ai-and-robotics/ 2023-06-15 https://www.biopharmatrend.com/business-intelligence/collaborative-open-source-approaches-are-the-new-norm-in-life-sciences-research-according-to-survey/ 2023-06-15 https://www.biopharmatrend.com/artificial-intelligence/the-rising-role-of-ai-enabled-digital-pathology-in-drug-discovery-689/ 2023-06-13 https://www.biopharmatrend.com/news/harnessing-ai-for-drug-discovery-certara-amplifies-codex-platform-capabilities-687/ 2023-06-11 https://www.biopharmatrend.com/news/collaboration-between-iktos-and-curreio-harnesses-ai-and-cryo-em-for-drug-discovery-685/ 2023-06-09 https://www.biopharmatrend.com/news/cepi-and-avaxzipen-partner-to-advance-needle-free-vaccine-delivery-aiming-for-equitable-global-access-684/ 2023-06-08 https://www.biopharmatrend.com/news/benevolentai-pioneers-ai-driven-drug-discovery-for-als-treatment-683/ 2023-06-07 https://www.biopharmatrend.com/news/owkin-advances-ai-in-drug-discovery-with-launching-50-million-mosaic-project-682/ 2023-06-06 https://www.biopharmatrend.com/news/reprocell-ibm-hncdi-pharmacology-ai-drug-discovery-681/ 2023-06-05 https://www.biopharmatrend.com/news/seqera-labs-joins-forces-with-genomics-england-to-boost-genomic-medicine-research-680/ 2023-06-02 https://www.biopharmatrend.com/news/fda-ind-approval-of-ai-derived-cancer-drug-ism3091-marks-a-milestone-for-insilico-medicine-679/ 2023-05-31 https://www.biopharmatrend.com/news/eli-lilly-collaborates-with-xtalpi-to-harness-ai-in-drug-discovery-678/ 2023-05-31 https://www.biopharmatrend.com/neurotech/neuralinks-journey-and-the-broadening-horizons-of-brain-computer-interface-technology-677/ 2023-05-26 https://www.biopharmatrend.com/news/valo-therapeutics-innovative-immuno-oncology-therapy-pepticrad-1-begins-human-trials-676/ 2023-05-23 https://www.biopharmatrend.com/news/mitsubishi-vc-arm-leads-75m-financing-for-pharmenables-ai-in-drug-discovery-efforts-675/ 2023-05-22 https://www.biopharmatrend.com/artificial-intelligence/syntekabios-supercomputing-is-transforming-early-stage-new-drug-discovery-674/ 2023-05-17 https://www.biopharmatrend.com/news/rna-interference-technology-fda-recognizes-sisafs-sirna-therapy-sis-101-ado-for-autosomal-dominant-osteopetrosis-treatment-673/ 2023-05-16 https://www.biopharmatrend.com/news/labgenius-ai-antibody-discovery-design-tcell-engager-optimisation-672/ 2023-05-15 https://www.biopharmatrend.com/news/bruker-acquires-zontal-boosting-digital-transformation-in-pharma-laboratories-669/ 2023-05-08 https://www.biopharmatrend.com/news/are-enzyme-powered-dna-circuits-the-future-of-biocomputing-668/ 2023-05-02 https://www.biopharmatrend.com/artificial-intelligence/from-qubits-to-cures-the-rise-of-quantum-computing-in-pharmaceutical-research-and-development-666/ 2023-04-27 https://www.biopharmatrend.com/artificial-intelligence/the-power-of-cloud-based-ai-drug-development-664/ 2023-04-27 https://www.biopharmatrend.com/artificial-intelligence/3-ways-big-data-and-machine-learning-revolutionize-drug-discovery-24/ 2023-04-21 https://www.biopharmatrend.com/news/retinai-and-boehringer-ingelheim-collaborate-on-ai-driven-drug-discovery-for-geographic-atrophy-treatment-665/ 2023-04-21 https://www.biopharmatrend.com/news/myricx-pharma-showcases-promising-pre-clinical-data-for-nmti-adc-programme-at-aacr-662/ 2023-04-20 https://www.biopharmatrend.com/news/enamine-and-endogenas-persistent-collaboration-paves-the-way-for-regenerative-medicine-advancements-663/ 2023-04-19 https://www.biopharmatrend.com/news/macomics-unveils-enigmactm-discovery-platform-at-aacr-661/ 2023-04-19 https://www.biopharmatrend.com/interviews/interview-with-paulo-di-tommaso-from-seqera-labs/ 2023-04-18 https://www.biopharmatrend.com/news/fda-collaborates-with-cerner-enviza-and-john-snow-labs-658/ 2023-04-12 https://www.biopharmatrend.com/news/psychogenics-introduces-ecube-an-ai-driven-platform-for-drug-discovery-in-neuropsychiatric-disorders-657/ 2023-04-11 https://www.biopharmatrend.com/business-intelligence/some-drugs-that-improve-price-competition-fall-through-the-cracks-of-fda-user-fees/ 2023-04-10 https://www.biopharmatrend.com/news/concertai-unveils-next-generation-clinical-trial-optimization-platform-cto-20-655/ 2023-04-08 https://www.biopharmatrend.com/news/introducing-lab-on-a-molecule-drug-discovery-approach-via-dna-nanoswitches-653/ 2023-04-07 https://www.biopharmatrend.com/news/introducing-pathexplore-a-game-changing-ai-tool-for-in-depth-tumor-microenvironment-exploration-654/ 2023-04-06 https://www.biopharmatrend.com/post/651-advancements-in-lipid-nanoparticles-for-targeted-gene-therapy-in-the-lungs/ 2023-04-05 https://www.biopharmatrend.com/artificial-intelligence/ai-powered-peptide-discovery-from-plant-sources-leads-to-a-breakthrough-in-muscle-recovery-649/ 2023-04-03 https://www.biopharmatrend.com/biotech-ventures/absci-and-other-ai-powered-biotechs-lead-the-way-in-antibody-discovery-648/ 2023-04-01 https://www.biopharmatrend.com/artificial-intelligence/qsimulate-brings-quantum-fingerprinting-to-the-forefront-to-improve-ai-drug-discovery-647/ 2023-04-01 https://www.biopharmatrend.com/news/gandeeva-therapeutics-and-moderna-join-forces-to-explore-ai-enabled-cryo-em-technology-646/ 2023-03-31 https://www.biopharmatrend.com/news/portal-innovations-empowers-biotech-ventures-in-chicago-and-atlanta-644/ 2023-03-29 https://www.biopharmatrend.com/news/mimetas-recent-milestones-in-advancing-drug-discovery-through-organ-on-a-chip-technology-645/ 2023-03-28 https://www.biopharmatrend.com/biotech-ventures/ai-drug-discovery-financing-roundup-unlearnai-iktos-denovai-and-more-643/ 2023-03-28 https://www.biopharmatrend.com/news/oxford-drug-design-and-phoremost-collaborate-to-advance-novel-cancer-therapeutics-discovery-640/ 2023-03-24 https://www.biopharmatrend.com/artificial-intelligence/the-potential-of-artificial-intelligence-to-transform-the-european-life-sciences-landscape-637/ 2023-03-23 https://www.biopharmatrend.com/news/altasciences-boosts-life-saving-drug-development-with-proscias-digital-pathology-platform-638/ 2023-03-21 https://www.biopharmatrend.com/news/proscia-enhances-preclinical-rd-platform-streamlining-pathology-workflows-for-faster-drug-safety-decisions-639/ 2023-03-20 https://www.biopharmatrend.com/interviews/breaking-through-the-investment-gap-mark-andrews-discusses-british-patient-capitals-life-sciences-fund/ 2023-03-14 https://www.biopharmatrend.com/interviews/medtech-a-likely-target-for-pe-investment-in-2023-insight-from-ropes-gray/ 2023-03-01 https://www.biopharmatrend.com/post/22-the-time-for-breakthroughs-in-antibiotics/ 2023-02-04 https://www.biopharmatrend.com/news/british-patient-capital-backs-groundbreaking-cancer-research-with-7-million-investment-in-grey-wolf-therapeutics-628/ 2023-01-26 https://www.biopharmatrend.com/interviews/democratizing-early-drug-discovery-through-artificial-intelligence-interview-with-syntekabio-ceo-jongsun-jung/ 2023-01-17 https://www.biopharmatrend.com/business-intelligence/rd-trends-driving-pharmaceutical-markets-in-2021-and-beyond/ 2022-12-29 https://www.biopharmatrend.com/interviews/interview-dr-eric-leire-ceo-of-genflow-biosciences/ 2022-12-28 https://www.biopharmatrend.com/interviews/innovation-and-sustainability-trends-for-2023-interview-with-jesper-jonsson-director-of-medical-devices-at-owen-mumford/ 2022-12-22 https://www.biopharmatrend.com/post/621-developing-cancer-weapons-with-better-aim/ 2022-12-15 https://www.biopharmatrend.com/artificial-intelligence/how-ai-boosts-research-on-molecular-glues-612/ 2022-11-28 https://www.biopharmatrend.com/post/598-7-companies-helping-exclude-animals-from-drug-discovery-research/ 2022-11-25 https://www.biopharmatrend.com/biotech-ventures/major-vc-rounds-for-ai-driven-biotechs-in-2022-595/ 2022-11-20 https://www.biopharmatrend.com/business-intelligence/case-studies/cancer-drug-discovery-and-development-using-radr-platform/ 2022-11-20 https://www.biopharmatrend.com/biotech-ventures/12-ai-powered-drug-discovery-startups-founded-in-2021-616/ 2022-11-14 https://www.biopharmatrend.com/tech-giants/how-big-tech-is-slowly-winning-pharmaceutical-markets-614/ 2022-11-08 https://www.biopharmatrend.com/interviews/turbocharging-phenotypic-drug-discovery-with-ai-the-case-of-targeting-mrna-biology-with-small-molecules/ 2022-11-06 https://www.biopharmatrend.com/post/611-innovative-drug-delivery-systems/ 2022-10-20 https://www.biopharmatrend.com/post/408-protein-degraders-take-industry-by-storm/ 2022-10-18 https://www.biopharmatrend.com/post/608-tech-meets-bio-in-scandinavian-region/ 2022-10-17 https://www.biopharmatrend.com/interviews/merging-quantum-mechanics-and-machine-learning-to-boost-drug-discovery/ 2022-10-14 https://www.biopharmatrend.com/biotech-ventures/technology-meets-biology-in-canada-607/ 2022-10-11 https://www.biopharmatrend.com/post/606-the-promise-of-daos-in-drug-discovery/ 2022-10-08 https://www.biopharmatrend.com/business-intelligence/case-studies/biopharmatrend-case-study-arctoris/ 2022-10-07 https://www.biopharmatrend.com/business-intelligence/a-market-review-of-dna-encoded-libraries-technology-in-drug-discovery/ 2022-10-05 https://www.biopharmatrend.com/business-intelligence/case-studies/e3-ligase-platform/ 2022-09-16 https://www.biopharmatrend.com/business-intelligence/case-studies/quaisar-computational-platform/ 2022-09-16 https://www.biopharmatrend.com/business-intelligence/case-studies/application-of-ai-driven-xanthos-platform-for-designing-protein-degraders/ 2022-09-15 https://www.biopharmatrend.com/post/596-a-race-for-better-3cl-inhibitors-to-cure-covid-19-copies-vs-innovators/ 2022-08-30 https://www.biopharmatrend.com/interviews/ancient-material-promises-to-solve-drug-delivery-pain/ 2022-08-17 https://www.biopharmatrend.com/interviews/interview-what-to-consider-before-launching-a-biotech-startup-in-2022/ 2022-08-15 https://www.biopharmatrend.com/next-gen-tools/current-trends-in-nanomedicine-fda-approved-nanoparticles-in-last-5-years-and-notable-trials-to-observe-584/ 2022-08-11 https://www.biopharmatrend.com/next-gen-tools/building-momentum-for-global-ai-driven-longevity-transformation-583/ 2022-08-10 https://www.biopharmatrend.com/post/190-13-drug-discovery-blogs-to-follow-for-professional-insight/ 2022-08-08 https://www.biopharmatrend.com/biotech-ventures/toronto-ai-startups-aim-high-in-drug-discovery-space-98/ 2022-08-02 https://www.biopharmatrend.com/post/578-3d-printed-muscle-tissues-for-drug-discovery-with-mantarraytm-platform-by-curi-bio/ 2022-08-01 https://www.biopharmatrend.com/post/577-transformational-egfr-drug-discovery/ 2022-07-29 https://www.biopharmatrend.com/business-intelligence/case-studies/case-study-cyclicas-chemical-probes-for-dcaf1/ 2022-07-21 https://www.biopharmatrend.com/artificial-intelligence/ai-powered-cryo-em-attracts-big-bucks-and-promises-to-disrupt-structural-biology-570/ 2022-07-19 https://www.biopharmatrend.com/news/endogena-therapeutics-doses-first-patient-with-novel-treatment-for-all-retinitis-pigmentosa-types-567/ 2022-07-15 https://www.biopharmatrend.com/business-intelligence/case-studies/featured-tech-bioz-platform/ 2022-07-14 https://www.biopharmatrend.com/business-intelligence/case-studies/how-astellas-achieves-operational-excellence-with-science-exchange/ 2022-07-14 https://www.biopharmatrend.com/business-intelligence/case-studies/biocompare-offline-order-attribution/ 2022-07-14 https://www.biopharmatrend.com/news/emerging-ai-player-in-the-drug-discovery-race-promises-to-screen-ultra-large-chemical-spaces-within-hours-560/ 2022-07-12 https://www.biopharmatrend.com/news/ai-hunt-for-als-treatment-continues-with-28-novel-targets-revealed-by-insilico-medicine-559/ 2022-07-08 https://www.biopharmatrend.com/news/paradigm4-brings-single-cell-community-closer-to-custom-made-cell-atlas-553/ 2022-06-30 https://www.biopharmatrend.com/news/in-the-largest-study-ai-found-to-increase-efficiency-of-breast-cancer-screening-when-combined-with-human-intelligence-544/ 2022-06-22 https://www.biopharmatrend.com/artificial-intelligence/how-data-sharing-technologies-bolster-ai-progress-in-medical-research-542/ 2022-06-17 https://www.biopharmatrend.com/news/owkin-announces-first-ever-large-scale-use-of-ai-to-enhance-clinical-trials-538/ 2022-06-11 https://www.biopharmatrend.com/interviews/interview-innovative-solution-for-the-treatment-of-low-testosterone-in-men-in-over-80-years/ 2022-06-08 https://www.biopharmatrend.com/news/insilico-medicine-snaps-up-60m-to-create-robotized-lab-of-the-future-525/ 2022-06-06 https://www.biopharmatrend.com/artificial-intelligence/virtual-reality-in-drug-discovery-more-useful-than-you-probably-think-515/ 2022-05-30 https://www.biopharmatrend.com/news/gearing-ai-to-fight-pandemics-a-novel-covid-19-drug-candidate-announced-513/ 2022-05-25 https://www.biopharmatrend.com/interviews/raj-indupuri-better-data-management-is-key-for-clinical-trials/ 2022-05-03 https://www.biopharmatrend.com/post/121-how-do-drug-manufacturers-select-the-right-contract-research-organizationcro/ 2022-04-28 https://www.biopharmatrend.com/interviews/merging-ai-and-quantum-computing-to-boost-drug-discovery/ 2022-04-26 https://www.biopharmatrend.com/interviews/interview-this-south-korean-company-is-at-the-forefront-of-ai-driven-drug-discovery/ 2022-04-20 https://www.biopharmatrend.com/interviews/interview-targeted-protein-degradation-a-new-approach-to-small-molecule-therapeutics/ 2022-04-18 https://www.biopharmatrend.com/interviews/the-evolving-culture-of-biotech-entrepreneurship/ 2022-04-14 https://www.biopharmatrend.com/interviews/combining-ai-and-quantum-mechanics-to-improve-drug-and-vaccine-discovery/ 2022-03-22 https://www.biopharmatrend.com/interviews/interview-bringing-cutting-edge-computational-power-to-biopharma-data-analysis/ 2022-02-22 https://www.biopharmatrend.com/post/464-are-we-keeping-up-with-resistance/ 2022-01-24 https://www.biopharmatrend.com/biotech-ventures/bringing-everything-on-demand-to-longevity-industry-452/ 2022-01-03 https://www.biopharmatrend.com/interviews/breakthrough-technology-solving-characterization-challenges-and-accelerating-biopharmaceutical-drug-development/ 2021-09-09 https://www.biopharmatrend.com/post/401-ups-and-downs-of-adenovirus-and-adeno-associated-virus-vectors-in-gene-therapy/ 2021-08-25 https://www.biopharmatrend.com/post/393-antisense-oligonucleotides-make-sense/ 2021-07-28 https://www.biopharmatrend.com/post/382-what-are-the-adc-drugs/ 2021-07-10 https://www.biopharmatrend.com/post/373-targeting-alzheimers-disease-a-new-wave/ 2021-05-24 https://www.biopharmatrend.com/interviews/alex-zhavoronkov-linking-chemistry-and-biology-using-artificial-intelligence/ 2021-03-28 https://www.biopharmatrend.com/industry-movers/cros-tap-into-ai-to-increase-value-proposition-292/ 2021-02-11 https://www.biopharmatrend.com/interviews/interview-how-d-wave-brings-quantum-computing-into-biology/ 2021-02-11 https://www.biopharmatrend.com/interviews/interview-this-company-brings-quantum-tech-into-protein-design/ 2021-01-22 https://www.biopharmatrend.com/interviews/a-company-on-the-cutting-edge-of-covid-19-vaccine-development/ 2020-09-28 https://www.biopharmatrend.com/interviews/a-new-way-to-work-with-data-in-life-sciences/ 2020-09-25 https://www.biopharmatrend.com/interviews/interview-expediting-drug-discovery-through-advanced-machine-learning/ 2020-09-18 https://www.biopharmatrend.com/interviews/interview-shaping-european-ai-regulation-to-secure-global-leadership-in-healthcare/ 2020-07-22 https://www.biopharmatrend.com/interviews/how-covid-19-catalyzed-ai-assisted-open-science-drug-discovery/ 2020-07-02 https://www.biopharmatrend.com/artificial-intelligence/the-increasing-potential-of-virtual-reality-in-drug-design-206/ 2020-06-19 https://www.biopharmatrend.com/post/191-virtual-immunostaining-for-digital-pathology/ 2020-06-03 https://www.biopharmatrend.com/interviews/advancing-off-the-shelf-cellular-medicines-to-fight-covid-19/ 2020-05-22 https://www.biopharmatrend.com/artificial-intelligence/11-inspiring-women-in-the-artificial-intelligence-for-drug-discovery-space-2020-184/ 2020-05-18 https://www.biopharmatrend.com/interviews/interview-hacking-metabolomics-with-ai-to-improve-clinical-research/ 2020-05-12 https://www.biopharmatrend.com/interviews/interview-building-canadas-life-sciences-community-and-thinking-global/ 2020-05-11 https://www.biopharmatrend.com/interviews/shaping-european-life-sciences-with-ai/ 2020-05-01 https://www.biopharmatrend.com/interviews/interview-using-generative-ai-to-rapidly-identify-novel-therapies-for-covid-19/ 2020-04-27 https://www.biopharmatrend.com/interviews/interview-the-rise-of-quantum-physics-in-drug-discovery/ 2020-01-28 https://www.biopharmatrend.com/business-intelligence/the-evolution-of-pharmaceutical-innovation-model/ 2020-01-02 https://www.biopharmatrend.com/interviews/applying-ai-to-shape-business-strategies-at-european-pharma-organizations/ 2019-12-18 https://www.biopharmatrend.com/interviews/interview-demystifying-the-role-of-artificial-intelligence-in-the-life-sciences/ 2019-12-02 https://www.biopharmatrend.com/interviews/interview-this-vancouver-based-startup-plans-to-boost-drug-design-with-ai/ 2019-11-06 https://www.biopharmatrend.com/next-gen-tools/how-is-ngs-the-next-big-thing-in-pharmacogenomics-107/ 2019-08-09 https://www.biopharmatrend.com/artificial-intelligence/pharma-companies-join-forces-to-train-ai-for-drug-discovery-collectively-97/ 2019-06-05 https://www.biopharmatrend.com/post/94-hot-research-investment-topics-in-drug-discovery-2019/ 2019-05-19 https://www.biopharmatrend.com/artificial-intelligence/2018-ai-is-surging-in-drug-discovery-market-72/ 2019-01-10 https://www.biopharmatrend.com/artificial-intelligence/democratizing-artificial-intelligence-in-pharmaceutical-research-76/ 2018-12-19 https://www.biopharmatrend.com/business-intelligence/top-7-trends-in-pharmaceutical-research-in-2018-and-beyond/ 2018-04-25 https://www.biopharmatrend.com/artificial-intelligence/2018-brings-surge-of-activity-in-the-ai-for-drug-discovery-space-53/ 2018-03-15 https://www.biopharmatrend.com/artificial-intelligence/high-throughput-quantum-chemistry-for-drug-discovery-towards-reaction-screening-55/ 2018-02-15 https://www.biopharmatrend.com/interviews/interview-adoption-of-ai-driven-tools-by-the-life-sciences-professionals-what-is-coming-in-2018/ 2018-01-18 https://www.biopharmatrend.com/artificial-intelligence/a-clear-example-of-ai-value-for-drug-discovery-has-arrived-51/ 2018-01-11 https://www.biopharmatrend.com/interviews/interview-the-current-status-of-ai-in-drug-discovery-and-looking-forward-into-2018/ 2017-12-26 https://www.biopharmatrend.com/post/47-three-insights-for-immuno-oncology-drug-discovery/ 2017-12-11 https://www.biopharmatrend.com/post/46-the-homunculus-metaphor-revisited-in-drug-discovery-body-on-a-chip/ 2017-12-06 https://www.biopharmatrend.com/artificial-intelligence/combining-genomics-and-ai-to-mine-new-drug-ideas-from-fungi-39/ 2017-09-24 https://www.biopharmatrend.com/artificial-intelligence/evaxion-biotech-uses-ai-to-develop-anticancer-and-antimicrobial-vaccines-37/ 2017-08-21 https://www.biopharmatrend.com/biotech-ventures/8-biopharma-trends-and-top-startups-to-follow-in-2017-31/ 2017-04-02 https://www.biopharmatrend.com/post/29-unveiling-hidden-drug-targets/ 2017-01-30 https://www.biopharmatrend.com/post/23-learning-from-nature-new-antibiotics-found-in-our-body/ 2016-10-25 https://www.biopharmatrend.com/biotech-ventures/a-new-player-in-the-area-of-anti-inflammatory-therapeutics-21/ 2016-09-23 https://www.biopharmatrend.com/news/one-cure-for-multiple-diseases-18/ 2016-07-21 https://www.biopharmatrend.com/authors/ https://www.biopharmatrend.com/authors/ayesha-khan/ https://www.biopharmatrend.com/authors/dr-karthik-muthusamy/ https://www.biopharmatrend.com/authors/victor-dillard/ https://www.biopharmatrend.com/authors/illia-petrov/ https://www.biopharmatrend.com/authors/adele-ruder/ https://www.biopharmatrend.com/authors/dr-alexander-jarasch/ https://www.biopharmatrend.com/authors/marina-hickson/ https://www.biopharmatrend.com/authors/karan-arora/ https://www.biopharmatrend.com/authors/andrii-lozoniuk/ https://www.biopharmatrend.com/authors/panos-karelis/ https://www.biopharmatrend.com/authors/henk-johan-streefkerk/ https://www.biopharmatrend.com/authors/michael-jewell/ https://www.biopharmatrend.com/authors/andrii-buvailo-phd/ https://www.biopharmatrend.com/authors/chris-de-savi/ https://www.biopharmatrend.com/authors/anthony-platt/ https://www.biopharmatrend.com/authors/caroline-green/ https://www.biopharmatrend.com/authors/ximena-rodriguez/ https://www.biopharmatrend.com/authors/davide-de-lucrezia/ https://www.biopharmatrend.com/authors/tim-sandle/ https://www.biopharmatrend.com/authors/viraj-mehta/ https://www.biopharmatrend.com/authors/huzaifa-ali/ https://www.biopharmatrend.com/authors/sabina-lee/ https://www.biopharmatrend.com/authors/bara-badwan/ https://www.biopharmatrend.com/authors/alex-brown/ https://www.biopharmatrend.com/authors/trevor-hutchings/ https://www.biopharmatrend.com/authors/ellen-burns/ https://www.biopharmatrend.com/authors/tudor-oprea-md-phd/ https://www.biopharmatrend.com/authors/dominik-tomicevic/ https://www.biopharmatrend.com/authors/andreas-dreps/ https://www.biopharmatrend.com/authors/dominika-wilczok/ https://www.biopharmatrend.com/authors/peter-jarowski/ https://www.biopharmatrend.com/authors/illia-terpylo/ https://www.biopharmatrend.com/authors/anastasiia-rohozianska/ https://www.biopharmatrend.com/authors/basem-goueli-mdphdmba/ https://www.biopharmatrend.com/authors/michael-whitworth/ https://www.biopharmatrend.com/authors/david-shlaes/ https://www.biopharmatrend.com/authors/alex-jones/ https://www.biopharmatrend.com/authors/dana-sokolova/ https://www.biopharmatrend.com/authors/rupert-colbourne/ https://www.biopharmatrend.com/authors/dr-khalid-fakhro/ https://www.biopharmatrend.com/authors/rick-martire/ https://www.biopharmatrend.com/authors/megan-deegan/ https://www.biopharmatrend.com/authors/isaac-smith/ https://www.biopharmatrend.com/authors/thomas-fessard/ https://www.biopharmatrend.com/authors/roman-kasianov/ https://www.biopharmatrend.com/authors/oleg-kucheriavyi-phd/ https://www.biopharmatrend.com/authors/caprice-sassano/ https://www.biopharmatrend.com/authors/ivan-kondratov/ https://www.biopharmatrend.com/authors/alexander-hustinx/ https://www.biopharmatrend.com/authors/louise-von-stechow/ https://www.biopharmatrend.com/authors/alfred-ajami/ https://www.biopharmatrend.com/authors/varun-debbeti/ https://www.biopharmatrend.com/authors/raj-indupuri/ https://www.biopharmatrend.com/authors/marco-schmidt/ https://www.biopharmatrend.com/authors/keith-thomas/ https://www.biopharmatrend.com/authors/sudhakaran-prabakaran-phd/ https://www.biopharmatrend.com/authors/natalia-honchar/ https://www.biopharmatrend.com/authors/halyna-buvailo-phd/ https://www.biopharmatrend.com/authors/anatolii-zagorodnii/ https://www.biopharmatrend.com/authors/paul-finn/ https://www.biopharmatrend.com/authors/josephine-fubara/ https://www.biopharmatrend.com/authors/joanna-bowie/ https://www.biopharmatrend.com/authors/andrey-doronichev/ https://www.biopharmatrend.com/authors/dimitrios-skaltsas/ https://www.biopharmatrend.com/authors/irina-bilous/ https://www.biopharmatrend.com/authors/luiza-moore/ https://www.biopharmatrend.com/authors/marco-lolaico/ https://www.biopharmatrend.com/authors/nikhil-pradhan/ https://www.biopharmatrend.com/authors/rasim-shah/ https://www.biopharmatrend.com/authors/david-vidal/ https://www.biopharmatrend.com/authors/liana-relina/ https://www.biopharmatrend.com/authors/bea-mann-phd/ https://www.biopharmatrend.com/m/company/1910-genetics/ https://www.biopharmatrend.com/m/company/a2a-pharmaceuticals/ https://www.biopharmatrend.com/m/company/atum/ https://www.biopharmatrend.com/m/company/aavantibio/ https://www.biopharmatrend.com/m/company/abcellera-biologics/ https://www.biopharmatrend.com/m/company/absci/ https://www.biopharmatrend.com/m/company/accent-therapeutics/ https://www.biopharmatrend.com/m/company/achilles-therapeutics/ https://www.biopharmatrend.com/m/company/aegera-therapeutics/ https://www.biopharmatrend.com/m/company/aegle-therapeutics/ https://www.biopharmatrend.com/m/company/agex-therapeutics/ https://www.biopharmatrend.com/m/company/aicure/ https://www.biopharmatrend.com/m/company/aigenpulse/ https://www.biopharmatrend.com/m/company/akcea-therapeutics/ https://www.biopharmatrend.com/m/company/alector/ https://www.biopharmatrend.com/m/company/allogene-therapeutics/ https://www.biopharmatrend.com/m/company/alnylam-pharmaceuticals/ https://www.biopharmatrend.com/m/company/anima-biotech/ https://www.biopharmatrend.com/m/company/antisense-therapeutics/ https://www.biopharmatrend.com/m/company/antiverse/ https://www.biopharmatrend.com/m/company/apexqubit/ https://www.biopharmatrend.com/m/company/aptose-biosciences/ https://www.biopharmatrend.com/m/company/aqemia/ https://www.biopharmatrend.com/m/company/arctoris/ https://www.biopharmatrend.com/m/company/arrakis-therapeutics/ https://www.biopharmatrend.com/m/company/arvinas/ https://www.biopharmatrend.com/m/company/arzeda/ https://www.biopharmatrend.com/m/company/asimov/ https://www.biopharmatrend.com/m/company/aspect-biosystems/ https://www.biopharmatrend.com/m/company/astrazeneca/ https://www.biopharmatrend.com/m/company/athersys/ https://www.biopharmatrend.com/m/company/atomic-ai/ https://www.biopharmatrend.com/m/company/atomwise/ https://www.biopharmatrend.com/m/company/axiom-bio/ https://www.biopharmatrend.com/m/company/basecamp-research/ https://www.biopharmatrend.com/m/company/beam-therapeutics/ https://www.biopharmatrend.com/m/company/beigene/ https://www.biopharmatrend.com/m/company/benchsci/ https://www.biopharmatrend.com/m/company/benevolentai/ https://www.biopharmatrend.com/m/company/bighat-biosciences/ https://www.biopharmatrend.com/m/company/bio-path-holdings/ https://www.biopharmatrend.com/m/company/bioage-labs/ https://www.biopharmatrend.com/m/company/bioxcel-therapeutics/ https://www.biopharmatrend.com/m/company/biocompare/ https://www.biopharmatrend.com/m/company/biophytis/ https://www.biopharmatrend.com/m/company/bioz/ https://www.biopharmatrend.com/m/company/bluerock-therapeutics/ https://www.biopharmatrend.com/m/company/boehringer-ingelheim/ https://www.biopharmatrend.com/m/company/brainomix/ https://www.biopharmatrend.com/m/company/c4-therapeutics/ https://www.biopharmatrend.com/m/company/c4x-discovery/ https://www.biopharmatrend.com/m/company/chain-biotechnology/ https://www.biopharmatrend.com/m/company/capsida-biotherapeutics/ https://www.biopharmatrend.com/m/company/cedilla-therapeutics/ https://www.biopharmatrend.com/m/company/celeris/ https://www.biopharmatrend.com/m/company/cellbox-labs/ https://www.biopharmatrend.com/m/company/cellink/ https://www.biopharmatrend.com/m/company/chemalive-sa/ https://www.biopharmatrend.com/m/company/circle-pharma/ https://www.biopharmatrend.com/m/company/cleara-biotech/ https://www.biopharmatrend.com/m/company/cloud-pharmaceuticals/ https://www.biopharmatrend.com/m/company/codiak-biosciences/ https://www.biopharmatrend.com/m/company/cohbar/ https://www.biopharmatrend.com/m/company/concerto-healthai/ https://www.biopharmatrend.com/m/company/congruence-therapeutics/ https://www.biopharmatrend.com/m/company/cradle/ https://www.biopharmatrend.com/m/company/creyon-bio/ https://www.biopharmatrend.com/m/company/culture-biosciences/ https://www.biopharmatrend.com/m/company/curevac/ https://www.biopharmatrend.com/m/company/cyclica/ https://www.biopharmatrend.com/m/company/ctd-holdings/ https://www.biopharmatrend.com/m/company/cyrus-biotech/ https://www.biopharmatrend.com/m/company/cytoreason/ https://www.biopharmatrend.com/m/company/daiichi-sankyo/ https://www.biopharmatrend.com/m/company/datavant/ https://www.biopharmatrend.com/m/company/deep-6-ai/ https://www.biopharmatrend.com/m/company/deep-genomics/ https://www.biopharmatrend.com/m/company/deepmind/ https://www.biopharmatrend.com/m/company/degron-therapeutics/ https://www.biopharmatrend.com/m/company/denali-therapeutics/ https://www.biopharmatrend.com/m/company/dinaqor/ https://www.biopharmatrend.com/m/company/dynabind/ https://www.biopharmatrend.com/m/company/eli-lilly/ https://www.biopharmatrend.com/m/company/emerald-cloud-lab/ https://www.biopharmatrend.com/m/company/emulate/ https://www.biopharmatrend.com/m/company/enamine/ https://www.biopharmatrend.com/m/company/endogena-therapeutics/ https://www.biopharmatrend.com/m/company/engine-biosciences/ https://www.biopharmatrend.com/m/company/engitix/ https://www.biopharmatrend.com/m/company/ensoma/ https://www.biopharmatrend.com/m/company/entasis-therapeutics/ https://www.biopharmatrend.com/m/company/enveda-biosciences/ https://www.biopharmatrend.com/m/company/envisagenics/ https://www.biopharmatrend.com/m/company/evaxion-biotech/ https://www.biopharmatrend.com/m/company/evox-therapeutics/ https://www.biopharmatrend.com/m/company/expansion-therapeutics/ https://www.biopharmatrend.com/m/company/exscientia/ https://www.biopharmatrend.com/m/company/far-biotech/ https://www.biopharmatrend.com/m/company/foxo-technologies/ https://www.biopharmatrend.com/m/company/finch-therapeutics/ https://www.biopharmatrend.com/m/company/flatiron-health/ https://www.biopharmatrend.com/m/company/formation-bio/ https://www.biopharmatrend.com/m/company/fosun-pharma/ https://www.biopharmatrend.com/m/company/gns-healthcare/ https://www.biopharmatrend.com/m/company/gatehouse-bio/ https://www.biopharmatrend.com/m/company/gensight-biologics/ https://www.biopharmatrend.com/m/company/generate-biomedicines/ https://www.biopharmatrend.com/m/company/generation-bio/ https://www.biopharmatrend.com/m/company/genflow-biosciences/ https://www.biopharmatrend.com/m/company/genmab/ https://www.biopharmatrend.com/m/company/genta-incorporated/ https://www.biopharmatrend.com/m/company/ginkgo-bioworks/ https://www.biopharmatrend.com/m/company/glen-research/ https://www.biopharmatrend.com/m/company/globavir-biosciences/ https://www.biopharmatrend.com/m/company/google-deepmind/ https://www.biopharmatrend.com/m/company/hafnium-labs/ https://www.biopharmatrend.com/m/company/haystack-sciences/ https://www.biopharmatrend.com/m/company/healx/ https://www.biopharmatrend.com/m/company/hesperos/ https://www.biopharmatrend.com/m/company/hifibio-therapeutics/ https://www.biopharmatrend.com/m/company/hitgen/ https://www.biopharmatrend.com/m/company/hotspot-therapeutics/ https://www.biopharmatrend.com/m/company/icon-plc/ https://www.biopharmatrend.com/m/company/iqvia/ https://www.biopharmatrend.com/m/company/iambic-therapeutics/ https://www.biopharmatrend.com/m/company/iktos/ https://www.biopharmatrend.com/m/company/immunai/ https://www.biopharmatrend.com/m/company/immunoprecise-antibodies/ https://www.biopharmatrend.com/m/company/innoplexus/ https://www.biopharmatrend.com/m/company/inovio-pharmaceuticals/ https://www.biopharmatrend.com/m/company/inscripta/ https://www.biopharmatrend.com/m/company/insilico-medicine/ https://www.biopharmatrend.com/m/company/insitro/ https://www.biopharmatrend.com/m/company/insmed/ https://www.biopharmatrend.com/m/company/insys-therapeutics/ https://www.biopharmatrend.com/m/company/intellia-therapeutics/ https://www.biopharmatrend.com/m/company/intelligencia-ai/ https://www.biopharmatrend.com/m/company/ionis-pharmaceuticals/ https://www.biopharmatrend.com/m/company/isarna-therapeutics/ https://www.biopharmatrend.com/m/company/isomorphic-labs/ https://www.biopharmatrend.com/m/company/iterum-therapeutics/ https://www.biopharmatrend.com/m/company/janssen-biotech/ https://www.biopharmatrend.com/m/company/johnson-johnson/ https://www.biopharmatrend.com/m/company/juno-therapeutics/ https://www.biopharmatrend.com/m/company/juvena-therapeutics/ https://www.biopharmatrend.com/m/company/karius/ https://www.biopharmatrend.com/m/company/kite-pharma/ https://www.biopharmatrend.com/m/company/korro-bio/ https://www.biopharmatrend.com/m/company/kuano/ https://www.biopharmatrend.com/m/company/kymera-therapeutics/ https://www.biopharmatrend.com/m/company/lexeo-therapeutics/ https://www.biopharmatrend.com/m/company/labgenius/ https://www.biopharmatrend.com/m/company/lantern-pharma/ https://www.biopharmatrend.com/m/company/legochembio/ https://www.biopharmatrend.com/m/company/life-biosciences/ https://www.biopharmatrend.com/m/company/lycia-therapeutics/ https://www.biopharmatrend.com/m/company/medsir/ https://www.biopharmatrend.com/m/company/mobilion/ https://www.biopharmatrend.com/m/company/macomics/ https://www.biopharmatrend.com/m/company/manabio/ https://www.biopharmatrend.com/m/company/manas-ai/ https://www.biopharmatrend.com/m/company/maxwell-biosciences/ https://www.biopharmatrend.com/m/company/medimmune/ https://www.biopharmatrend.com/m/company/medable/ https://www.biopharmatrend.com/m/company/medidata-solutions/ https://www.biopharmatrend.com/m/company/mendelai/ https://www.biopharmatrend.com/m/company/menten-biotechnology-labs/ https://www.biopharmatrend.com/m/company/mesoblast/ https://www.biopharmatrend.com/m/company/meta-pharmaceuticals/ https://www.biopharmatrend.com/m/company/metagenomi/ https://www.biopharmatrend.com/m/company/microbiotica/ https://www.biopharmatrend.com/m/company/mimetas/ https://www.biopharmatrend.com/m/company/mind-the-byte/ https://www.biopharmatrend.com/m/company/moderna-therapeutics/ https://www.biopharmatrend.com/m/company/monomer-bio/ https://www.biopharmatrend.com/m/company/myricx-pharma/ https://www.biopharmatrend.com/m/company/nabla-bio/ https://www.biopharmatrend.com/m/company/nanome/ https://www.biopharmatrend.com/m/company/neubase-therapeutics/ https://www.biopharmatrend.com/m/company/nimble-therapeutics/ https://www.biopharmatrend.com/m/company/noetik/ https://www.biopharmatrend.com/m/company/nonexomics/ https://www.biopharmatrend.com/m/company/novartis/ https://www.biopharmatrend.com/m/company/nuritas/ https://www.biopharmatrend.com/m/company/nurix/ https://www.biopharmatrend.com/m/company/nvidia/ https://www.biopharmatrend.com/m/company/okra/ https://www.biopharmatrend.com/m/company/bioptic/ https://www.biopharmatrend.com/m/company/owkin/ https://www.biopharmatrend.com/m/company/oisin-biotechnologies/ https://www.biopharmatrend.com/m/company/olaris/ https://www.biopharmatrend.com/m/company/omnia-biosystems/ https://www.biopharmatrend.com/m/company/oncodna/ https://www.biopharmatrend.com/m/company/orbis-medicines/ https://www.biopharmatrend.com/m/company/orna-therapeutics/ https://www.biopharmatrend.com/m/company/paigeai/ https://www.biopharmatrend.com/m/company/paradigm4/ https://www.biopharmatrend.com/m/company/paratek-pharmaceuticals/ https://www.biopharmatrend.com/m/company/pathai/ https://www.biopharmatrend.com/m/company/pathos/ https://www.biopharmatrend.com/m/company/perspix-biotech/ https://www.biopharmatrend.com/m/company/pharmcadd/ https://www.biopharmatrend.com/m/company/pharmacelera/ https://www.biopharmatrend.com/m/company/phenomic-ai/ https://www.biopharmatrend.com/m/company/plexium/ https://www.biopharmatrend.com/m/company/pluristem-therapeutics/ https://www.biopharmatrend.com/m/company/polaris-quantum-biotech/ https://www.biopharmatrend.com/m/company/poolbeg-pharma/ https://www.biopharmatrend.com/m/company/postera/ https://www.biopharmatrend.com/m/company/proqr-therapeutics/ https://www.biopharmatrend.com/m/company/prokarium/ https://www.biopharmatrend.com/m/company/promega/ https://www.biopharmatrend.com/m/company/proscia/ https://www.biopharmatrend.com/m/company/proteinqure/ https://www.biopharmatrend.com/m/company/psychogenics/ https://www.biopharmatrend.com/m/company/quanthealth/ https://www.biopharmatrend.com/m/company/quartzy/ https://www.biopharmatrend.com/m/company/qubit-pharmaceuticals/ https://www.biopharmatrend.com/m/company/receptorai/ https://www.biopharmatrend.com/m/company/recode-therapeutics/ https://www.biopharmatrend.com/m/company/rebiotix/ https://www.biopharmatrend.com/m/company/recursion-pharmaceuticals/ https://www.biopharmatrend.com/m/company/relay-therapeutics/ https://www.biopharmatrend.com/m/company/remix-therapeutics/ https://www.biopharmatrend.com/m/company/reverie-labs/ https://www.biopharmatrend.com/m/company/riverlane/ https://www.biopharmatrend.com/m/company/roivant-sciences/ https://www.biopharmatrend.com/m/company/rubedo-life-sciences/ https://www.biopharmatrend.com/m/company/saama/ https://www.biopharmatrend.com/m/company/sanofi/ https://www.biopharmatrend.com/m/company/scholar-rock/ https://www.biopharmatrend.com/m/company/schrodinger/ https://www.biopharmatrend.com/m/company/science-exchange/ https://www.biopharmatrend.com/m/company/scientistcom/ https://www.biopharmatrend.com/m/company/scribe-therapeutics/ https://www.biopharmatrend.com/m/company/secarna-pharmaceuticals/ https://www.biopharmatrend.com/m/company/seres-therapeutics/ https://www.biopharmatrend.com/m/company/shape-therapeutics/ https://www.biopharmatrend.com/m/company/sisaf/ https://www.biopharmatrend.com/m/company/silicon-therapeutics/ https://www.biopharmatrend.com/m/company/sirenas/ https://www.biopharmatrend.com/m/company/spirochem/ https://www.biopharmatrend.com/m/company/sporebio/ https://www.biopharmatrend.com/m/company/standigm/ https://www.biopharmatrend.com/m/company/sterna-biologicals/ https://www.biopharmatrend.com/m/company/stoke-therapeutics/ https://www.biopharmatrend.com/m/company/storm-therapeutics/ https://www.biopharmatrend.com/m/company/strateos/ https://www.biopharmatrend.com/m/company/syntekabio/ https://www.biopharmatrend.com/m/company/synthace/ https://www.biopharmatrend.com/m/company/synthego/ https://www.biopharmatrend.com/m/company/tandemai/ https://www.biopharmatrend.com/m/company/taysha-gene-therapies/ https://www.biopharmatrend.com/m/company/teckro/ https://www.biopharmatrend.com/m/company/telix-pharmaceuticals/ https://www.biopharmatrend.com/m/company/tempus/ https://www.biopharmatrend.com/m/company/terray-therapeutics/ https://www.biopharmatrend.com/m/company/teselagen/ https://www.biopharmatrend.com/m/company/tessera-therapeutics/ https://www.biopharmatrend.com/m/company/totient/ https://www.biopharmatrend.com/m/company/touchlight-genetics/ https://www.biopharmatrend.com/m/company/trinetx/ https://www.biopharmatrend.com/m/company/trialspark/ https://www.biopharmatrend.com/m/company/trialize/ https://www.biopharmatrend.com/m/company/turbine-ai/ https://www.biopharmatrend.com/m/company/twist-bioscience/ https://www.biopharmatrend.com/m/company/unity-biotechnology/ https://www.biopharmatrend.com/m/company/unlearnai/ https://www.biopharmatrend.com/m/company/unnatural-products/ https://www.biopharmatrend.com/m/company/vaccibody/ https://www.biopharmatrend.com/m/company/valo-health/ https://www.biopharmatrend.com/m/company/valo-therapeutics/ https://www.biopharmatrend.com/m/company/vandria/ https://www.biopharmatrend.com/m/company/variational-ai/ https://www.biopharmatrend.com/m/company/vaxxinity/ https://www.biopharmatrend.com/m/company/verge-genomics/ https://www.biopharmatrend.com/m/company/verve-therapeutics/ https://www.biopharmatrend.com/m/company/voyager-therapeutics/ https://www.biopharmatrend.com/m/company/x-chem-pharmaceuticals/ https://www.biopharmatrend.com/m/company/xaira-therapeutics/ https://www.biopharmatrend.com/m/company/xtalpi/ https://www.biopharmatrend.com/m/company/zageno/ https://www.biopharmatrend.com/m/company/zapata-computing/ https://www.biopharmatrend.com/m/company/zentraxa/ https://www.biopharmatrend.com/m/company/zymergen/ https://www.biopharmatrend.com/m/company/biotxai/ https://www.biopharmatrend.com/m/company/e-therapeutics/ https://www.biopharmatrend.com/m/company/eclinical-solutions/ https://www.biopharmatrend.com/m/company/etherna/ https://www.biopharmatrend.com/m/company/ibio/ https://www.biopharmatrend.com/m/company/myneo/ https://www.biopharmatrend.com/m/company/vevo-therapeutics/